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In this time of economic downturn, it is becoming increasingly important for
organizations, including those in public health, to “prove their worth,” to show the value
in improvement strategies. Health agencies have learned to discuss impact in terms of
health outcome and mortality/morbidity measures. However, it is critical that these
impacts are also expressed in a way that shows cost-efficiency and economic benefit
especially for promising, evidence-based public health interventions. Although several
methods of economic evaluation including cost-effective analysis, cost-utility analysis,
or cost-benefit analysis and return on investment (ROI) have been used in social
sciences and health research, fewer examples are found in public health systems
research.
This dissertation explores common methods for financially quantifying value in
public health system change, and these methods are used to assess cost-benefit in a realworld example: the development of the Center for Community Health (CCH), an
academic–public health partnership anchored in the University of Rochester Medical
Center (URMC). The value of the University’s investment in public health is analyzed
by quantifying the costs and benefits of the Center. A multi-methods, retrospective

analysis of this naturally occurring experiment was conducted including collecting
revenue data (internal and extramural) and expenses data over time, as well as
interviewing key informants to quantify the Center’s contribution to the Essential
Services of a public health department.
With the University’s annual contribution of around $1 million, the CCH has
accumulated a $6.5 million annual budget within 6 years. This has resulted in an
expanded public health workforce of 60 individuals and increased essential public
health services delivered to the community including surveillance, research, policy
investment, cancer screenings, prevention programs, and individual counseling. In
addition to the increased budget and shifting to extramural funding, the CCH has
achieved cost-effectiveness through disease prevention through programs and services.
This work serves as a practical and duplicable example for public health
practitioners and systems researchers of how economic analysis of system chance can
be done. An analytical framework is presented, as well as a discussion of barriers and
shortcomings for measuring value in public health interventions.
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CHAPTER I
INTRODUCTION
Statement of the Problem
The rising costs of health care and the decreasing amount of financial resources
provides both an opportunity and a challenge to the field of public health. The
opportunity: limited resources for health have prompted the exploration of communitybased prevention as a potential cost-saving alternative to expensive medical testing,
hospital stays, surgery, and long-term treatment for chronic disease. The challenge: the
public health system, experts in prevention, must adjust its capacities to meet changing
demands, including innovative strategies to prevent chronic disease as well as systems
and evaluation mechanisms that assure fiscal accountability.
As the United States continues to debate the most effective solution for faster
economic recovery, one point is clear: The increasing cost of health care must be
contained. Spending on hospital visits, medications, and other health care has been
steady for the last few years at about 17.9% of GDP (Gross Domestic Product). Health
spending accounts for $1.2 trillion or 19% of the fiscal year 2013 federal spending budget
of $6.3 trillion (www.usgovernmentspending.com). In order to bend the cost curve in
health care, any strategy to reduce the federal deficit must include a plan to reduce
spending on health care.

1

2
Most spending in health supports health care delivery, with physician/clinical
services accounting for 20% and hospital care accounting for 31% of national health
expenditures (Goodell & Ginsburg, 2008). Much less health spending is dedicated to
preventing illness, which, if effective, could decrease the cumulative medical costs
associated with treating chronic and later-stage disease. Although national data on public
health spending are imperfect and often difficult to discover, estimates consistently
indicate that less than 5% of national health spending is devoted to public health activities
(Mays & Smith 2011). In 2008, estimates put national public health spending at
approximately 3% of the $2.4 trillion ($2.7 trillion in 2011) national health expenditures,
or $240 per capita (Leider, Sellers, Shah, Pearsol, & Jarris, 2012). Although there are
some resources from private foundations and local government to support specific public
health prevention strategies, overall funding streams are scarce.
Although medical treatment often provides the latest technology, testing, and
pharmaceuticals to address even the most unique of circumstances, this is relevant only to
those who are sick and who are able to access medical care. Health care reform,
insurance plans, and safety net clinics have been established to improve health care
access and even preventive screening to monitor movement from a state of healthiness to
needed intervention. Much less effort has been expended in assuring that people remain
in a healthy state and this is the role of public health. The 1988 Institute of Medicine
(IOM) report “The Future of Public Health” defined public health as “fulfilling society’s
interest in assuring conditions in which people can be healthy.” The public health system
is concerned with addressing the social determinants of health, which means building an
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environment for health, and this is the earliest form of primary prevention. Public health
has the greatest opportunity to improve health outcomes and realize significant health
efficiency and effectiveness by concentrating efforts in early prevention, often
accomplished through policy change and cross-disciplinary partnerships. However,
public health leaders are often ill-equipped to advocate for resources and policies and
often lack the skills to make the economic case to decision makers that public health is
cost-effective.
Policymakers need to be equipped with better information from the public health
sector in order to make sound investments and to optimize health outcomes. Crossdisciplinary comparisons of interventions, for example, clinical medicine interventions
versus community-based interventions, would also be helpful; however, there are
methodological barriers, such as differences in standard measures of outcomes and
different timeframes needed to realize success. Policymakers need relative costeffectiveness studies of different approaches across different sectors, including the impact
of non-healthcare interventions (Kindig et al., 2003).
With the passage of the Patient Protection and Affordable Care Act (ACA) Public
Law 111-148 in March 2010, President Barack Obama focused health reform on access
and prevention in an unprecedented fashion. Several provisions of the ACA target the
public health infrastructure and accountability, as summarized in Table 1.
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Table 1
Investment in Population and Community-Based Prevention, Education and Outreach
Programs and Relevant Provisions of the Affordable Care Act as Passed
Section

Provision

Sec. 4002

Establishes a “Prevention and Public Health Investment Fund” to provide for
expanded and sustained national investment in prevention and public health
programs that builds up from $500 million in FY 2010 to $2 Billion in
FY2015 and each fiscal year thereafter.

Sec. 4001

Creates an interagency council to establish a national prevention and health
promotion strategy.

Sec. 4201

Creates “Community Transformation Grants” (CTG) to state and local
governmental agencies and community based organizations for the
implementation, evaluation and dissemination of proven evidence-based
community preventive health activities to reduce chronic disease rates,
address health disparities and develop stronger evidence-base of effective
prevention.

Sec. 5313

Authorizes the Secretary to award grants to States, public health departments,
clinics, hospitals, FQHCs and other nonprofits to promote positive health
behaviors and outcomes in medically underserved areas through the use of
community health workers.

Sec. 4003

Directs CDC Director to convene an independent “Community Preventive
Services Task Force” to review the scientific evidence related to the
effectiveness, appropriateness, and cost-effectiveness of community
preventive interventions and recommendations, to be published in the “Guide
to Community Preventive Services”.

Sec. 4301

Directs HHS/CDC to fund research in the area of public health services and
systems that examines evidence-based practices relating to prevention, with a
particular focus on high priority areas identified in the National Prevention
Strategy or Healthy People 2020 and including comparing community based
public health interventions in terms of effectiveness and cost.

Affordable Care Act Overview: Selected Provisions (American Public Health Association 2012)

Public health departments are being asked to do more than ever before, and to
demonstrate that they can do so efficiently and effectively. Many local health
departments are staffed with employees trained for traditional health department work—
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focused on infectious disease, screenings, and health fairs, for example. They may not be
equipped for the new public health agenda, which includes conducting evidence-based
interventions, exploring policy and environmental solutions, completing robust
evaluations, and assessing economic value of any program, service, or system change.
This requires not only resourcefulness and partnership, but new skills in economic and
financial analysis only recently applied to public health. The focus of public health has
shifted from infectious disease control to chronic disease prevention, from proximal risk
factors for disease to more distal risk factors and intervention (Scutchfield & Howard,
2011). These changes require health departments to consider new and unexpected
partnerships and to build new capacity-strengthening public health systems.
An Institute of Medicine (IOM) report in 2003, “The Future of the Public’s Health
in the 21st Century,” identified strategies to engage the governmental public health
departments with other partners in the community. The call to partnership necessitates
governmental public health entities becoming more accountable for what they do and
more open to functioning through collaborations and partnerships (Turnock & Barnes,
2007).
The 2003 IOM report laid the groundwork for current public health system
change. Figure 1 illustrates the focus on partnership to increase capacity, emphasizing
that it is not just the public health system’s responsibility to ensure the conditions of the
community’s health.
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Figure 1. The Public Health System Source: The Future of the Public’s Health
(IOM, 2003)

The IOM report focused on several areas of action and change for the
improvement of population health,1 including:
adopting a focus on multiple determinants of health,
strengthening the public health infrastructure,
building partnerships,
developing systems of accountability,
emphasizing evidence, and
improving communication.

1

Population health is the focus of public health efforts. It refers to “the health of a population as
measured by health status indicators and as influenced by social, economic and physical environments,
personal health practices, individual capacity and coping skills, human biology, early childhood
development and health services” (Federal, Provincial, and Territorial Advisory Committee on Population
Health, 1999).
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The role of public health is changing, and many public health functions might be
better served through partner organizations such as universities or academic medical
centers that conduct essential health-related research. Public health agencies that have
strong agency partnerships, such as those with universities, hospitals, or community
groups, are associated with a higher likelihood of monitoring health status, diagnosing
and investigating health problems, enforcing regulations, and conducting research
(Scutchfield, Knight, Kelly, Bhandari, & Vasilescu, 2004). In this time of economic
hardship and tremendous system change, it is becoming increasingly important for
organizations, including those in public health, to “prove their worth,” to be able to
demonstrate value in any improvement strategy. Often to this point, health agencies have
discussed impact in terms of health outcome and mortality/morbidity measures.
However, it is critical that these impacts are also expressed in a way that shows costefficiency and economic benefit, especially for promising, evidence-based public health
interventions. Evidence-based interventions are those that have strong or sufficient
scientific outcomes that demonstrate they are effective.
Prevention, partnership, and accountability are reoccurring themes throughout the
Affordable Care Act. Prevention and partnership are familiar, but accountability is
relatively new to public health organizations. Only through scientifically demonstrating
to decision makers and policy leaders that public health is a “good investment” will the
public health system hope to gain continued allocated resources for system infrastructure
and capacity. Unfortunately, public health practitioners and researchers are not typically
taught this type of analysis. Typical public health professionals are health educators,
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nurses, epidemiologists, environmental health specialists, and physicians who may not
have encountered economic analysis or public health finance in their training or
experience.
When the economics of public health are understood, sound financial investments
can be evaluated and presented as an advocacy tool for decision makers. A clear and
recent example of this is the Mahoning Health District, an academic health department
affiliated with Northeast Ohio Medical University, which functions as a local health
department. Facing dire economic outlook and fear of closure, the health officer
partnered with public health systems researchers to examine financial deficits and their
underlying causes. The agency used the information to implement strategies based on
sound financial decisions that led to the turnaround of the agency finances. Within a few
years, the department was able to show a positive financial position and remain open.
(Honoré, Stefanak, & Dessens, 2012).
Significance of the Research
Very little is known about the financial and economic characteristics of public
health systems and even less is known about how investments in public health impact
service delivery and health outcomes. The current evidence on efficiency and costeffectiveness issues in public health practice focuses on specific health promotion and
disease prevention interventions, which are often clinically based. Very little evidence
exists regarding the public health delivery system as a whole (Mays et al., 2009). Mays
et al. suggest that new research is needed to develop methods for analyzing efficiency in
public health practice and within public health systems.
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The 2013 campaign for National Public Health Week was “Public Health is ROI:
Save Lives, Save Money” (American Public Health Association [APHA], 2013). The
literature for the National Public Health Week references several examples of how public
health offers return on investment (ROI) by saving lives and by saving money (Dilley,
Harris, Boysun, & Reid, 2012; Gase et al., 2011; Magnus et al., 2012; Ormond, Spillman,
Waidmann, Caswell, & Tereshchenko, 2011). Return on investment is an economic
performance measure used to evaluate the efficiency of an investment. To calculate ROI,
the financial benefit (return) of an investment (less the cost) is divided by the cost of the
investment; the result is expressed as a percentage or a ratio. Although public health does
save lives, this is not an indication of ROI in the traditional sense, but rather an indication
of the effectiveness of public health. In addition, the examples given in the APHA
material for saving money are all examples of mathematical modeling and simulations to
estimate cost savings for several specific interventions. Although this is valuable
information and methodologically appropriate, the research literature is lacking practical
evaluations and measures of return on investments in public health practices. In addition,
there are not many, if any, observational examples in the literature of investment in
public health organizations as a whole and the specific benefits associated with the
resulting system change and infrastructure support. Very few examples exist in public
health systems research literature. Mays and Smith (2011) have contributed to this small
body of literature with their recent study demonstrating that increases in public health
spending (total annual spending of the local public health agency, divided by the total
population residing within the jurisdiction) can be statistically associated with decreases
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in preventable death. The APHA selection of ROI as the theme of 2013’s National
Public Health Week and the examples given in the promotional material demonstrate the
admirable intent to encourage economic evaluation in public health but also demonstrate
the confusion surrounding these methods of analysis.
Public Health Systems and Services Research (PHSSR) is the “field of study that
examines the organization, financing, and delivery of public health services within
communities and the impact of those services on public health” (Mays, Halverson, &
Scutchfield, 2004; Scutchfield & Patrick, 2007). Similar to Health Services Research and
following from its development, PHSSR concentrates on the delivery and financing of
public health service delivery, not clinical or medical care. The public health systems
research community in 2011-2012 met with practitioners, policy makers, educators and
other stakeholders to develop a research agenda. The Robert Wood Johnson Foundation
(RWJF) and the Centers for Disease Control and Prevention (CDC) led the initiative to
update the research agenda for Public Health Systems and Services Research with
assistance from the National Coordinating Center for PHSSR and Altarum Institute.
The four topic areas for the research agenda are public health workforce, public
health systems structure and performance, public health financing and economics, and
public health information and technology (Scutchfield, Pérez, Monroe, & Howard, 2012).
Several intriguing research questions emerged for public health financing and economics
in the categories of fiscal analysis, financing mechanisms and costs, performance, and
outcomes (Consortium, 2012).
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This dissertation work will begin to address some of these concerns by
contributing to the literature answering questions from the PHSSR National Research
Agenda for public health financing and economics, specifically:
What measures provide the most valid and reliable indicators of the financial
performance of public health agencies?
How do investments in public health strategies influence the need for
downstream spending on medical care and/or social services?
Carande-Kulis, Getzen, and Thacker (2007) added to the discussion regarding the
research agenda for public health economics by confirming that there is a need to broaden
the scope beyond intervention-level analysis to the type of issues that are addressed and
the methods applied when examining public health systems and policies. This
commentary reiterates that analytical tools have been applied for estimating the economic
impact of diseases and injuries, and addressing the cost-effectiveness, and cost-benefit of
interventions, especially clinical, to prevent disease and promote health. However, very
little study has been done on the economics of public health functions such as monitoring
health status, diagnosing and investigating community health problems, informing people
about health issues, and developing policies that support community health efforts to
modify unhealthy behaviors (Carande-Kulis et al., 2007).
There are many potential barriers to economic analysis in public health systems
research. First, effective interventions often involve policy change, surveillance,
partnerships, and other system changes whose long-term outcomes are difficult to
quantify. Second, many public health practitioners who implement interventions are not
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researchers and often lack expertise in designing logic models, defining measureable
objectives, and conducting appropriate economic analysis. Third, lack of consistent data
tracking and lack of prospective case-control research/evaluation design in most public
health interventions makes pre-post evaluation, including economic analysis, difficult. In
addition, many outcomes in public health are abstract constructs such as a “healthy
community” that are difficult to operationalize. There is no agreed-upon measure that
defines improvement in community health. These limitations, evaluation methods, and
effective study frameworks will be discussed in this dissertation work.
Purpose of the Study
The purpose of this study is to explore how economic analysis and financial
thinking can be applied to public health in an understandable and replicable way to create
meaningful evidence to inform policy change. This dissertation research first explores
economic methods, system frameworks, and barriers to financial and economic analysis
while providing references to tools and resources helpful to other public health systems
researchers and practitioners. The primary focus of the dissertation concentrates on a
real-world example of an economic evaluation analyzing a public health system
investment and the change in value resulting from the change. This analysis focuses on a
public health system partner, and measures the value return on investment in the context
of a new adaptable framework conducive to public health practitioners. This example
represents neither a macro-level analysis nor an intervention-level analysis, but rather an
intermediate, organizational system perspective.
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The University of Rochester has partnered with the Monroe County Department
of Public Health (MCDPH) to develop the Center for Community Health (CCH), an
academic center within the University of Rochester Medical Center (URMC). I
measured the value of the University’s investment in public health by quantifying the
costs and benefits of the CCH, which includes both start-up and maintenance costs, and
both short-term and long-term outcomes including significant expansion of the public
health workforce, and millions of dollars in grants and contracts for public health
initiatives. I demonstrate how the CCH has increased the capacity of the public health
system in Rochester and use an example through a case study of how this capacity can
lead to measureable health outcomes that increase value.
The health department (MCDPH) has collaborated with the University of
Rochester Medical Center for decades, and this relationship culminated in the
establishment of the CCH. The CCH provides a delivery model whereby public health
employees, administrators, and researchers are hired and supported by the University of
Rochester to fulfill essential public health services. This model is unique in its
formalization of the partnership between local public health and academia in a long-term
organizational structure that strives to increase the infrastructure capacity for community
health improvement.
Created in 1997, the Center for Rochester’s Health was formed through a
memorandum of understanding between the MCDPH and the URMC to address key
issues that emerged from the community health assessment and planning process called
HealthAction. This was the first iteration of the CCH. Staff was hired by the URMC, but
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they worked at the MCDPH contributing to the public health workforce. A steering
committee, comprised of leadership from both URMC and MCDPH governed the work
of the Center. Several interventions were initiated through the Center including health
professional education activities, the Racial and Ethnic Adult Disparities in Immunization
Initiative (READII) Rochester, and the Finger Lakes Office of Surveillance and
Epidemiology (FLOSE). Work continued until 2004 when URMC officially made
community health its fourth core mission. Then in 2006, the Center for Community
Health was established from the Center for Rochester’s Health to complete the work of
the fourth core mission and staff was moved to URMC. In 2008 the CCH was relocated
in city-based facility to enhance its awareness and accessibility, especially among at-risk
populations. CCH continues to do public health work and collaborates often with the
MCDPH. The CCH mission is to join forces with the community to eliminate health
inequalities and improve health through research, education, and service. This is
accomplished through several programs and initiatives focused on chronic disease
prevention including cancer services, diabetes prevention programs, and counseling. In
addition, CCH has health policy and environmental initiatives, as well as research and
surveillance efforts.
The CCH was developed through an initial investment from the University of
Rochester in public health. UR leadership is interested in knowing if their investment
yielded a return and what benefits have been generated from the investment. A
framework was developed to add context to this analysis and then effectiveness and costefficiency calculations were done to assess the return on the UR investment over time. In
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addition to adding to public health systems research literature, the results of this
evaluation will be immediately translated to decision makers as URMC leadership
contemplates future funding for the CCH.
Research Question
In addition to the questions presented in the PHSSR research agenda, the main
research question for this dissertation work asks if investing in public health system
capacity provides value, and whether that value change can be quantified in economic
terms. More specifically:
Does the University of Rochester’s investment in the development and
maintenance of the Center for Community Health, a partnership extension of the
local public health system, provide a value benefit either financially or in the
health of the community?
This question is answered by exploring the system results of the investment that the
University of Rochester has made in the establishment and maintenance of the Center for
Community Health. Financial gains, process outcomes, and long-term impacts on the
community’s health are studied.
Definition of Terms
Economics is the study of decisions about the use of goods and services in an
environment of limited resources. Economics can be applied to health (health
economics) and is used frequently at the Centers for Disease Control and Prevention
(CDC) and for public health decision making (Messonnier, 2006). The CDC maintains a
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web page on public health economics and tools to encourage economic analysis in public
health (www.cdc.gov/stltpublichealth/pheconomics/index.html). Economic evaluation is
the comparison of two or more alternative courses of action in terms of both their costs
and consequences (Drummond, Sculpher, Torrance, O’Brien, & Stoddart, 2005). There
are several types of economic evaluations or methods, and they differ primarily in how
benefits are measured. Three of the most common evaluations are cost-benefit analysis
(compares money in with money out), return-on-investment or ROI (a type of costbenefit analysis), cost-effectiveness analysis (compares money in with the desired health
effect out), and cost-utility analysis (compares money in with quality-adjusted life years
or QALY). For economic analysis in health it is important to remember that measuring
the value and quality of life is not objective. Ethical considerations and what constitutes
a “valuable life” further complicate health economic evaluation.
Economics was introduced to public health research to make transparent and fair
decisions on the basis of the best tools and data possible. Cost-benefit and costeffectiveness analysis of vaccines are considered by the Advisory Committee on
Immunization Practices (ACIP) when it makes recommendations, and the U.S.
Prevention Services Task Force and the Task Force on Community Preventive Services
both include economic information in their recommendations when available
(Messonnier, 2006). Although several methods of economic evaluation including cost
effectiveness analysis, cost utility analysis, or cost-benefit analysis and return on
investment (ROI) have been used in social sciences and health research, fewer examples
are found in public health.
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Value is a difficult term to define. Merriam-Webster (n.d.) defines value as the
relative worth, utility, or importance of something. Something of value is something that
is worthwhile and assessing value is deciding whether or not an activity is worthwhile.
The value of an intervention depends on one’s perspective and the beliefs and priorities
of the person who is assessing value. Good value can be defined as providing substantial
health benefit per dollar spent net of any savings, without necessarily saving money
(Maciosek, Coffield, Flottemesch, Edwards, & Solberg, 2010).
Chapter Summary
The need for decision makers to understand and appreciate analysis that
demonstrates the value of public health is critical to the profession’s sustainability,
especially when funding is tight and decisions must be justified. Economic evaluation
and the ability to translate economic analysis into practice and advocacy can help policy
makers and practitioners make efficient use of valuable resources.
Public health practitioners would benefit from economic frameworks and
methodologies that are easy to understand and adaptable to unique and unusual
circumstances and system changes. This dissertation will explore model frameworks and
economic methods, and demonstrate their use by assessing the value change resulting
from an investment in public health. A case study will be presented to demonstrate how
one specific intervention can contribute to the value added from a public health system
investment. In summary, public health system changes such as the development of
public health-academic partnerships are not obvious frameworks for cost-benefit analysis.
My research will explore methods for successful application of economic analysis, and
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will give examples of how already established economic methods can be used without
elaborate expertise and with minimal resources to quantify value in public health
investment.

CHAPTER II
LITERATURE REVIEW
The Value of Public Health
Public health is clearly a leader in community-based prevention strategy and
implementation. The classic definition of public health is from C.E.A. Winslow, one of
the leading figures in the history of public health. In a 1920 retirement speech, Winslow
describes public health as
the science and art of preventing disease, prolonging life, and promoting physical
health and efficiency through organized community efforts for the sanitation of
the environment, the control of community infections, the education of the
individual in principles of personal hygiene, the organization of medical and
nursing services for the early diagnosis and preventive treatment of disease, and
the development of the social machinery which will ensure to every individual in
the community a standard of living adequate for the maintenance of health.
(Winslow, 1920)
Focus on early prevention and community engagement is evident even in this formative
stage of the discipline.
The 1988 Institute of Medicine (IOM) report “The Future of Public Health”
summarizes this early definition of public health in shorter form as “fulfilling society’s
interest in assuring conditions in which people can be healthy.” The IOM report defined
public health’s core functions in three broad categories: assessment of public health,
policy development, and assurance that public health services are available. These
categories are further defined as the 10 Essential Public Health Services, listed in Table 2.
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Table 2
The Ten Essential Services of Public Health

Assessment

1. Monitor health status to identify and solve community health problems
2. Diagnose and investigate health problems and health hazards in the community
3. Inform, education and empower people about health issues

Policy

4. Mobilize community partnerships and action to identify and solve health problems
5. Develop policies and plans that support individual and community health efforts
6. Enforce laws and regulations that protect health and ensure safety

Assurance

7. Link people to needed personal health services and assure the provision of health
care when otherwise unavailable
8. Assure competent public and personal health care workforce
9. Evaluate effectiveness, accessibility, and quality of personal and population-based
health services
10. Research for new insights and innovative solutions to health problems

Public health departments have varying degrees of success accomplishing the
essential services and many survey tools have been developed to gauge the performance
of health departments based on the essential services including the National Public Health
Performance Standards surveys. Very few studies utilize other methods of assessing
performance (Erwin, 2008). Public health focus has shifted over the years; for example,
policy development and research have not traditionally been at the forefront of activities
for public health workers but are the focus of the latest IOM report on public health
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(IOM, 2011). Even though policy development is one of the major functional categories
of public health, only a few researchers have examined the relationship between law and
public health system performance (Burris, Mays, Scutchfield, & Ibrahim, 2012).
Increased integration of policy development and informing decision makers has become
an important factor in public health system functioning and community health outcomes.
In addition, Healthy People 2020 encourages the use of public health law research and
public health systems research to help understand improvements in community health
outcomes (Office of Disease Prevention and Health Promotion and U.S. Department of
Health and Human Services, 2011).
Does Public Health Provide a Net Financial Benefit?
Is focusing more resources on public health an effective strategy to reduce health
care costs? Public health is focused on primary prevention which prioritizes upstream,
protective interventions that ensure people stay healthy for as long as possible and reduce
excess demand on an overextended health care delivery system (Milstein, Homer, Briss,
Burton, & Pechacek, 2011). There is very little research literature examining the costeffectiveness of typical public health interventions such as building a healthy
environment, enacting health-promoting policy, or community-based programs.
Although public health systems research lacks economic analysis, many prevention
strategies that are typically found in medical settings have been studied for costeffectiveness and cost-efficiency. Health systems research seems to be ahead of public
health systems research in studying economic impact, perhaps due to the limited scope of
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clinically based interventions and the increased ability to measure time and financial
resources spent on clinical interventions as opposed to community-based work.
Evidence on cost has been collected since the 1970s when cost-effectiveness
analysis was first applied to health and medicine (Russell, 2009). Clinical primary and
secondary prevention measures and treatment measures show similar distributions for
cost-effectiveness (cost per healthy year) when Russell examined the literature. Figure 2
summarizes 279 cost-effectiveness ratios for preventive interventions and 1,221 ratios for
treatments from cost-effectiveness ratio studies published between 2000 and 2005,
regardless of effected disease. At each level, treatment and prevention show similar cost
effectiveness.

Figure 2. Distribution of Cost-Effectiveness Ratios for Preventive Measures and
Treatments for Existing Conditions (Russell, 2009)
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However, the prevention measures considered in Figure 2 are limited to clinical
interventions, typically screening and counseling measures, and often secondary or
tertiary prevention. Although this type of work is done in public health, usually with
sexually transmitted disease and HIV, often public health is concentrated on more
upstream primary prevention strategies with greater potential for cost savings in
preventing chronic conditions. Vaccination against pneumococcal pneumonia is a costsaving example and reduces medical spending for adults ages 50-64 with congestive heart
failure, chronic lung disease, diabetes, and other chronic conditions (Russell, 2009).
Carefully considering the setting of the intervention, target populations, frequency of
intervention, the prevention program’s effectiveness in reducing chronic disease, and
component costs can increase the likelihood that a prevention intervention is costeffective.
Although the evidence is confusing and depends on several characteristics of the
prevention intervention, a strong consensus has emerged that a core set of evidence-based
clinical preventive services offer high economic value. The National Commission on
Prevention Priorities (NCPP) examined 25 preventive services and found 10 that were
clearly cost-effective (cost less than $14,000 per QALY) (Woolf et al., 2009). This core
set of preventive services offers high economic value, but only a small subset—childhood
vaccines, aspirin prophylaxis, and smoking cessation—yield actual cost savings.
Preventive care that decreases costs is cost-saving. In contrast, if the benefits are
sufficiently large compared to the costs, the intervention is “cost-effective” even if it does
not save money. Most preventive care is not cost-saving, but much of it is cost-effective,
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providing significant benefit in quality-adjusted life years. An intervention can be
expensive; however, it can provide several additional healthy disease-free years and
therefore be categorized as cost-effective, even if the intervention does not save any
money overall.
Although prevention measures are not often cost-saving, the research has been
done primarily in clinical settings and often on more secondary prevention such as
screening and smoking cessation counseling. However, the work of public health is
focused on community and often on interventions much further “upstream.” Public
health’s role of “assuring the conditions in which people can stay healthy” is a clear call
to address the social determinants of health, and this very early prevention strategy is,
theoretically, the most cost-saving approach to health care. Healthy People 2020 strives
for the elimination of preventable death and illness, but states that this will occur only by
examining root causes and societal determinants (Office of Disease Prevention and
Health Promotion, 2011).
What determines if a person will be healthy? Health outcomes are determined by
many factors, as illustrated in Dahlgren and Whitehead’s (1991) historic model of
determinants of health (Figure 3). Health is determined by genetic factors such as age,
sex, and race and non-health determinants such as income, education, and environment.
Each of these determinants affects health; however, the broadest, most far-reaching
effects can be accomplished by impacting the socioeconomic, cultural, and environmental
conditions.
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Figure 3. The Primary Determinants of Health (Dahlgren & Whitehead, 1991)

To what extent each of these determinants impacts health outcomes has been the
focus of substantial research. In an often cited article, McGinnis and Foege (1993) were
among the first to measure the relative contributions of various determinants to early
death of individuals in the United States. They found that genetic predisposition accounts
for 30% of premature deaths, whereas health care accounted for an additional 10%.
According to the authors, the remaining 60% of proportional contributions to premature
death was due to the “social determinants of health,” specifically 40% to behavioral
patterns, 15% to social circumstances, and 5% to environmental exposure.
In 2004, Mokdad, Marks, Stroup, and Gerberding confirmed McGinnis and
Foege’s estimates using identical study design that involved using a MEDLINE search of
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the literature for relative risk and prevalence measures combined with estimates of cause
of death from mortality data reported to the Centers for Disease Control and Prevention.
An enormous body of literature supports the view that differences in health are
determined as much by social circumstances that underlie them as by the biologic process
that mediate them. McGinnis and Foege (1993) summarized the role of health behaviors
as a leading cause of death and labeled them the “actual causes of death.” Later updated
by Mokdad et al. (2004), these studies concluded that approximately half of all deaths in
the U.S. could be attributed to factors such as smoking, physical inactivity, poor diet, and
alcohol use (Mokdad & Remington, 2010). Improving the health of individuals is bidirectionally linked to improving the health of communities where they live, work, and
play.
Public health has considerable capacity to reduce health care spending by
reducing or eliminating the leading causes of disease, death, and disability with costefficient, population-based interventions, and linking clinical care to community
prevention (Rein & Ogden, 2012). Public health, according to Rein and Ogden, can help
decrease costs by centering efforts on primary prevention and gives examples of
childhood immunization as one cost-saving measure. Chronic disease, which is largely
preventable, causes 7 of 10 deaths in the United States and consumes more than 70% of
the nation’s health spending. Recent time-series studies estimate that nationally as much
as 50% of the gains in life expectancy in the U.S. since 1950 are attributable to the public
health focus on diet, tobacco exposure, and other community interventions (Mays &
Smith, 2011).
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In a macroscopic analysis of the U.S. health care system, Milstein and his team
(2011) estimated the relative and combined health and economic impacts of three
intervention strategies mentioned in the Affordable Care Act of 2010: coverage, care, and
protection. Specifically, each strategy was examined by analyzing their likely
consequences over a 25-year period. The three approaches were (1) Coverage: expand
health insurance; (2) Care: deliver better preventive and chronic care; and (3) Protection:
establish healthier behavioral and environmental conditions. The impact of approach 3 is
more gradual, but is the only approach that lowered both the number of premature deaths
and reduced costs, while alleviating demand on already limited primary care delivery
system. In addition, Milstein showed that the interventions worked synergistically. The
baseline simulation showed that when the protection intervention was added to coverage
and care, 90% more lives would be saved and costs would be reduced by 30% in year 10.
In summary, cost-efficiency and cost-effectiveness studies are prevalent in
clinical prevention interventions, but much less research has been conducted on the early
prevention strategies typical of public health systems. There are many reasons for this,
including the amount of time often needed for behavior change, the lack of randomized
controlled trials in public health, and the difficulty in proving causation. Since early
interventions addressing social, behavioral, and environmental determinants of health can
decrease mortality and morbidity, there is a huge potential for cost savings by investing
in public health and its functions.
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Summary of Current Work in Economic Analysis of Public Health
Economic evaluation can occur at many levels in public health. Macro-level
analysis examines public health investments at a national level and looks at benefits that
impact the entire health care system and beyond. For example, Trust for America’s
Health (2009) issued a report that states for every $10 investment per person per year in
proven community-based disease prevention programs, the country could save more than
$16 billion annually within 5 years. This is a return of $5.60 for every $1 spent. These
findings are based on a model developed by researchers at the Urban Institute and using
evidence-based studies in the literature surrounding physical activity, nutrition, and
smoking. Researchers examined interventions that cost less than $10 per person and
through meta-analysis of the literature, calculated rates of reduction in diabetes, high
blood pressure, heart disease, kidney disease, stroke, cancer, arthritis, and COPD with the
interventions. Also from the literature, annual costs associated with each of these
diseases were calculated and applied to the rates of disease and to the population numbers
to calculate averted costs. Mays and Smith’s (2011) study linking public health spending
to declines in preventable deaths is another example of macro-level analysis. They found
that mortality rates fell between 1.1% and 6.9% for each 10% increase in public health
spending over the course of the 12 years studied.
There is also micro-level analysis that occurs with intervention and programmatic
economic evaluation. Several of these studies are listed in the literature and include cost
savings related to interventions such as discussing aspirin use with high-risk adults,
immunizing children, and tobacco-use screening and cessation programs (Maciosek et al.,
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2006). Studies at this level can be found using varied economic methods, time frames,
inclusion criteria for costs and benefits, and study designs and, therefore, often yield
varying results. Decision makers who try to interpret the evidence are often left confused
on the general question of “Does prevention save money?”
There is the added confusion in public health economic analysis that the cost of an
intervention might lead to an environmental change or a behavior change that does not
lead to a quantifiable outcome until the change yields health impact, which may be years
later. For example, many public health interventions focus on developing built
environments conducive to active lifestyles, with the hope that people living in that
environment will be less likely to be overweight or obese. Studies have quantified the
added expenses attributable to obesity. One recent macro-level study estimates that
annual medical expenditures are between 6.7% and 10.7% lower in the absence of
obesity (Trogdon, Finkelstein, Feagan, & Cohen, 2012); therefore, any successful attempt
to lower obesity should have some degree of cost savings over time. Several of these
examples can be found in the literature and are summarized in Table 3, leading to the
conclusion that public health prevention in general is a good investment.
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Table 3
Health Behaviors and Projected Health Outcomes
Examples of Studies Showing Intervention Impact on Disease or Behavior Rates
Study

Target Behavior

Condition

Findings

Brownson
(2000)

Physical Activity

Cardiovascular Disease

Of people who had access to walking
trails, 38.3% used them. Of these
users, 55.2% increased their amount of
walking

CDC (2005)

Physical Activity,
Weight Loss

Diabetes

By losing 5 to 7% of body weight and
getting just 2.5 hours of physical
activity a week, people with prediabetes can cut their risk for
developing type 2 diabetes by about
60%

Dauchet
(2005)

Nutrition

Cerebrovascular
Disease

Risk of stroke was decreased by 11%
for each additional portion per day of
fruit and 3% for each added
portion/day of vegetables.

Felson (1997)

Weight Loss

Arthritis

40% increase in risk per 10 pound
weight gain and 60% increase in risk
per 5 unit BMI increase

HHS (2003)

Nutrition

Cardiovascular
Disease, Cholesterol

A 10% decrease in cholesterol levels
may result in an estimated 30%
reduction in the incidence of coronary
heart disease

Joshipura,
et al. (2001)

Nutrition

Cardiovascular Disease

Each additional serving of fruits and
vegetables per day was associated with
a 4% lower risk for coronary heart
disease

McGinnis &
Foege (1993)

Nutrition

Cardiovascular Disease

22 to 30% of CHD deaths are due to
dietary factors, especially increased
consumption of cholesterol and
saturated fat and a decreased
consumption of fiber

Nutrition

Cancer

The proportion of all cancer deaths
attributable to diet is 35%

Nutrition

Diabetes

45% of diagnosed cases are due to poor
diet, inactivity and obesity

Weight Loss

Diabetes

16% reduction in diabetes risk per
kilogram of weight loss.

Hamman
(2006)

(Trust for America’s Health, 2009)
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Although there are entire registries of cost-effectiveness analysis research for
clinical preventive interventions, much less is available for community-based programs,
typical in public health. A few large-scale studies are promising. The Trust for
America’s Health’s (2009) Prevention for a Healthier America studied community
programs in July 2008 and concluded that an investment of $10 per person per year in
proven community programs to increase physical activity, improve nutrition, and prevent
smoking and other tobacco use could save the country more than $16 billion annually
within 5 years. This is a return of $5.60 for every $1.00 invested. The Commonwealth
Fund estimated that elimination of tobacco use and obesity would lower national health
expenditures by $474 billion over 10 years, which is the excess cost of care for people
with preventable chronic disease and those without (Woolf et al., 2009). Baicker, Cutler,
and Song (2010) found that medical costs declined by about $3.27 for every dollar spent
on worksite wellness programs, and that absenteeism costs fell by about $2.73 for every
dollar spent. Since 60% of Americans get their health insurance coverage through an
employment-based plan, this is an important venue for investments in health.
Researchers debate whether preventive services deliver sufficient savings, but it
may be more important to ask whether an intervention offers good value for the dollar,
regardless of cost savings. Good “value” can be defined as providing substantial health
benefit per dollar spent net of any savings, without necessarily saving money (Maciosek
et al., 2010). For example, public health policies that reduce risk behaviors for obesity
have value even without cost-efficiency studies. Obesity continues to add to the
economic burden on both public and private payers. Per capita medical spending for the
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obese is $1,429 higher per year (42%) than for someone normal weight (Finkelstein,
Trogdon, Cohen, & Dietz, 2009). Using data from the Medical Expenditure Panel
Survey (MEPS), researchers estimate that the annual excess medical care cost of four
diseases associated with obesity and smoking (Type 2 Diabetes, hypertension, heart
disease, and stroke) is currently $238 billion (Waidmann, Ormond, & Bovbjerg, 2011).
National Agenda and Funding for Public Health
Although health care reform has been discussed by policy leaders for many years,
the Patient Protection and Affordable Care Act (PL111-149) (ACA) was the first policy
to link health care reform to funding for public health and prevention (Waidmann et al.,
2011). On March 23, 2010, health care reform became law when President Obama
signed the ACA legislation. Many provisions of the ACA directly benefit public health
including the new policy development mechanism of the National Prevention Council
and a significant source of funding called the Prevention and Public Health Fund (PPHF)
(Bovbjerg, Ormond, & Waidmann, 2011). The fund originally promised $15 billion over
10 years to build public health capacity by supporting programs, medical screenings, and
research related to public health and prevention. The ACA puts public health in the
spotlight by adding new funding, creating new infrastructure, and encouraging
innovations especially for addressing chronic conditions at the population level.
The ACA makes a significant statement in support of prevention; however,
federal funding for public health initiatives remains vulnerable. In fact, in February 2012,
the fund was cut by $6.25 billion over 9 years in order to offset a scheduled cut to

33
Medicaid physician payments. Some ACA provisions such as the Prevention Fund were
protected by multi-year appropriations. However, unlike entitlement funding for clinical
care, federal funds for public health programs are annually appropriated even if they were
authorized in the ACA, which means advocacy is needed each year to sustain funding
(Bovbjerg et al., 2011).
Funding for public health is needed. The National Association of County and
City Health Officials (NACCHO, 2012) surveyed local health departments nationwide in
early 2012 to measure the impact of the economic recession on local health department
budgets, staff, and programs. The survey showed that during 2011, 57% of all local
health departments reduced or eliminated services in at least one program area, which is
more than any year since the recession began in 2008. In addition, over 5,000 staff
positions were eliminated in the last half of 2011. Reductions in funding for public
health have resulting in the loss of nearly 50,000 state and local public health jobs over
the previous 3-year period (Rein & Ogden, 2012). The ratio of public health workforce
to U.S. population has dropped from 220 per 100,000 in 1980 to 158 per 100,000 in
2000, already then far below the projected need (Gebbie & Turnock, 2006). Although
the prolonged recession no doubt contributes to this job loss, there appears to be a
disconnect between reducing costs through prevention and funding the infrastructure
most capable of doing this work.
With limiting resources, public health has to set priorities and refocus its agenda.
Should the ACA funds be used to fill shortfalls in core public health programs neglected
during the recession, or should public health transform its infrastructure and address new
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goals? Prioritizing the public health agenda is necessary to effectively advocate for a
clear vision. Research is needed to track the downstream effects of this new
unprecedented spending in public health through the ACA (Mays & Smith, 2011). It will
be important to study the association between public health spending and population
health status, a link already examined by Mays and Smith, who found that after
controlling for other factors, mortality rates fell by between 0.5 % and 4.3% for each 10%
increase in public health spending (p < 0.05) over 15 years. Medical care spending per
person also fell by 0.8% for each 10% increase in public health spending per capita
(p < 0.05) (Mays & Smith 2011). Mays and Smith concluded that higher levels of
spending may contribute to improved population health if resources are allocated to
activities that are effective in reducing health risks, and if these activities are targeted
successfully to population groups at risk.
Most health care costs are associated with chronic disease. The prevalence of
chronic disease is projected to continue growing, and if not slowed, health care costs
associated with these conditions will continue to grow. Cardiovascular disease, cancer,
and diabetes now cause 70% of U.S. deaths and account for nearly 75% of health care
expenditures. The second IOM report, “Future of the Public’s Health,” in 2003 suggests
that slowing the growth of chronic disease will require prevention beyond acute care
medicine. The IOM report highlighted the critical importance of the multiple
determinants of population health, and the social-ecological framework, in future efforts
to improve the population’s health. Doctors and hospitals focus on producing health
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care, but what is needed is a focus on health and preventing sickness, which is usually the
focus of public health activities (Asch & Volpp, 2012).
The Trust for America’s Health (2009) recent report, Prevention for a Healthier
America, agrees and states that the country will never be able to contain health care costs
until we start focusing on how to prevent people from getting sick in the first place.
There is a need to put emphasis on improving the choices we make that affect our risk for
preventable disease (Trust for America’s Health, 2009). The U.S. prioritization of health
care rather than health is evident in the U.S. poor performance in life expectancy and
other major health outcomes compared with other developed countries. The U.S. spends
extravagantly on clinical care, but sparingly on population-based prevention that
influences health more than medical services (IOM, 2003).
So, although there is a great opportunity with ACA and the Prevention Fund
resources, public health systems will need to adapt by concentrating on policy change,
early community interventions, and prevention of chronic conditions more than infectious
disease. In addition, it is becoming increasingly important for public health practitioners
and researchers to feel comfortable conducting and discussing economic analysis.
Barriers to Economic Analysis in Public Health
The health benefits of prevention are intuitive, but is there economic proof that
community-based preventions save money? Unlike with acute care interventions, it is
often difficult to demonstrate economic value in community prevention, even when the
health value is obvious (Woolf et al., 2009). Prevention interventions strive for healthy
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behaviors which are difficult to change, and once changed take time to translate to health
and economic benefit. There is also an inherent economic conflict in prevention.
Effective prevention prolongs life, which leads to increased medical care use and
therefore costs, even among the healthiest survivors. In addition, promoting access to
services and screenings conflicts with promoting efficiency and cost-cutting in the short
term since more people will use health services. These increased usage costs should,
however, be offset by the difference in the cost of care for people with chronic disease
and those without. Prevention also can reduce absenteeism and improve productivity at
work and school (Waidmann, Ormond, & Spillman, 2012), factors not quantified in this
study, but worthy of mention.
Methods of economic evaluation are well established for clinical intervention;
however, there are several methodological challenges when applying these methods to
public health interventions. This may account for the relatively few complex
interventions delivered at the population level that include economic evaluation. Four
key methodological challenges were identified by Weatherly and colleagues (2009) after
reviewing several economic evaluation studies from the public health literature:
1. It is difficult to conduct randomized controlled trials in public health;
therefore, it is hard to determine causation and attribution of health benefits.
Without randomized controlled trials, there are threats to the validity of the
reported health effects, most commonly selection bias and measurement error.
In addition, there is often not a comparison or control group, and therefore
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there might be unrelated pathways that account for observed differences
(Miller, Dickerson, Smith, & Ory, 2010).
2. With broad-based system change, costs and benefits extend beyond the health
intervention to education, economy, and other disciplines. These are often
difficult to quantify.
3. Standard approaches to measuring health benefit, i.e., QALY, may be
inadequate for measuring public health effects
4. Standard economic evaluation methods focus on maximizing health gains on
the target intervention group, rather than on equity or distribution of health
gains across the population.
There are a number of ways to overcome these challenges and Weatherly calls for pilot
studies and more methodological research to apply economic methods to public health
interventions.
It is difficult to quantify outcomes in public health. There is a need for a clear
definition of public health activity and what are important outcomes of that activity.
Public health systems research has a broad focus, and there are no “uniformly stated aims
to serve as system wide indicators of quality” (Ingram, Bernet, & Costich, 2012). If there
are not clear expected outcomes, it is near impossible to quantify value. What measure
shows that a public health system change has been effective? When measuring public
health system change, it is helpful to review the essential functions of local public health
as outcomes indicators. In the landmark 1988 Institute of Medicine (IOM) original study,
“The Future of Public Health,” the core functions are defined in three broad categories:
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assessment of public health, policy development, and assurance that public health
services are available. These categories are further defined as the 10 Essential Public
Health Services. The Essential Services provide a working definition of public health
and a guiding framework for the responsibilities of local public health systems, which
also provides a framework for the National Public Health Performance Standards
(NPHPS) Program that monitors the essential services (http://www.cdc.gov/nphpsp/
essentialServices.html).
Quantifying costs is important for all economic methods. Medical intervention
costs include costs for screening, counseling, pharmaceutical treatments, follow-up
diagnostic tests, hospitalizations, etc. However, there are no clear standards for cost
capture analyses procedures in behavior interventions (Ritzwoller, Sukhanova, Gaglia, &
Glasgow, 2009). Differences in methodology result in inconsistencies and difficulty in
comparing costs of varied interventions. Some tools are being developed to standardize
cost capture; most importantly for public health systems research is the Public Health
Return on Investment tool being developed Dr. Glen Mays with the help of ASTHO
(Association of State and Territorial Health Officers) and the CDC. This standardization
of information is critical to decision analysis, especially when deciding on resource
allocation.
It is also difficult to quantify the money invested in public health. Public health
finance is defined as a “field of study that examines the acquisition, utilization, and
management of resources for the delivery of public health functions and the impact of
these resources on population health and the public health system” (Honoré & Amy,
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2007). Its primary focus is on resources needed and acquired for the delivery of essential
public health services and other functions of the system. A better understanding of public
health finance has been identified as a core need by leaders in the field of public health
systems research. There is a growing need to measure levels and types of spending in
local public health and demonstrate value and cost-effectiveness of public health services
(Leider et al., 2012). Public health finance literature, especially as it relates to public
health systems, needs further review to identify gaps and to prioritize areas of future
research.
Although a substantial body of literature exists that examines financial ratios used
to assess efficiency of corporations and governments, the literature on financial ratio
analysis applied to local public health departments is scarce (Suarez, Lesneski, &
Denison, 2011). Research on financial analysis of health departments is necessary to
determine the most appropriate ways to assess whether dollars spent on public health
services are worthwhile. Public health administrators must produce more health with
fewer resources than ever before, so knowledge on how to achieve efficiencies in service
delivery is critical. Suarez et al. make several recommendations for how financial
analysis research can progress, including developing uniform data formats, teaching
financial management to public health students, and training health department staff on
financial ratio analysis. Suarez et al. also suggest that more research is needed on the use
and effectiveness of financial indicators.
The long time frame needed to assess benefits, both health benefits and financial
benefits, presents a problem for economic assessment as well as political influence.
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Often public health interventions lead to healthy environments that eventually encourage
difficult behavior change. The health consequences resulting in the behavior change may
take several years to occur. Cost-benefit analysis places a monetary value on the
significant intervention-related outcomes, based on benefits expected to accrue over the
life course of participants (Kuklinski, Briney, Hawkins, & Catalano, 2011). Potential
savings include all medical costs for avoided treatments or reduced costs for less
intensive, earlier stage treatments (Maciosek et al., 2006). Substantial cost offsets
associated with less use of health care resources is usually long term, greater than 5 years;
however, most cost-benefit analyses are done in a much shorter time frame (Ritzwoller et
al., 2009).
There is an inherent difficulty in measuring cost-efficiency with public health;
public health prolongs life, and it cost more to live longer (Woolf et al., 2009). In
essence, prevention leads to increased use of medical services over time. However,
preventing people from getting sick definitely has value in terms that economic
evaluation cannot easily capture. What matters more is value, the health benefit per
dollar invested, and this is measured in cost-effectiveness analysis. Good value can be
defined as providing substantial health benefit per dollar spent, without necessarily
saving money. Woolf explains that although an intervention might NOT be costeffective, the resultant behavior change might be cost-effective. For example, an
exercise intervention might not be cost-effective; however, there is substantial value and
cost savings with decreased obesity that occurs secondary to increases in exercise (Woolf
et al., 2009).
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Public health economic analysis provides another unique challenge: Metrics
developed must be feasible and understandable for already overworked public health staff
to use routinely. Research often uses academic terms and calculations that local health
department staff does not understand (Neumann, Jacobson, & Palmer, 2008). In addition,
public health economic researchers might seek to publish in journals not typically read by
public health managers and directors. Academic researchers evaluating the economics
of public health investments should increase focus on the needs of public health
professionals so they are better able to measure the value of their own services (Neumann
et al., 2008). Public health services do often provide a positive return on investment
especially long-term, but practitioners often do not know how to discuss this effectively
with policy makers. Public health practitioners need to have a quick and easy set of
replicable economic evaluation tools and a clear, understandable framework to make
credible decisions when discussing the merit of existing and potential programs.
Practitioners and public health systems researchers must continue to collaborate to
better understand the efficiency and effectiveness of public health activities (Ingram et
al., 2012). When research findings are grounded in practice-based questions regarding
value, a convincing political case is made for better targeted funding. Local public health
departments may achieve more community impact if they use financial ratio analysis to
monitor performance, increase capacity, and achieve their mission and vision which
would improve the health of the population in that community (Suarez et al., 2011).
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Policy Implications of Economic Analysis
Cost-effectiveness analysis is a powerful analytic tool for assessing the value and
efficiency of health care intervention. Although there are limited examples in the
literature of cost-effectiveness analysis applied to public health systems change,
especially in the United States, academics and policy analysts are increasingly requesting
these studies to inform health policy decisions (Bryan, Sofaer, Siegelberg, & Gold,
2009). It is important to keep in mind that cost-effectiveness of a service might vary
across regions and different organizational arrangements, and the resultant health
outcomes often aren’t realized for years. Benefits, like costs, are often difficult to
estimate, and often economic tools are not usable, and the data systems are not uniform
or easy to understand.
Public policy makers are very interested in funding cost-effective health
programs. Cost savings and cost-effectiveness are important to policy makers because
chronic disease, which has become the dominant source of mortality and cost in the U.S.,
is driven by risk factors that are largely preventable (Goodell, Cohen, & Neumann,
2009). The U.S. Preventive Services Task Force (USPSTF) and the Community
Preventive Services Task Force both have established an evidence-based approach to
decision and policy making by rating intervention on effectiveness based on systematic
reviews (Chattopadhyay & Carande-Kulis, 2004). The USPSTF does not evaluate costeffectiveness studies of preventive services in developing its recommendations, and only
includes economic evaluation for informative purposes. If an intervention is found to be
effective after review, any economic information is included in the recommendation
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based on any cost studies conducted in the literature used for the reviewed. Such review
has been done on the cost effectiveness of screening asymptomatic adults for abdominal
aortic aneurysms and exercise tolerance testing for coronary heart disease
(http://www.uspreventiveservicestaskforce.org/3rduspstf/chd/chdsum1.htm). The
Community Preventive Services Task Force makes recommendations for interventions
based on systematic reviews of the literature also. Once a recommendation is made, a
review is conducted to assess the quality of any relevant economic evaluations and to
summarize those findings along with the recommendations in the Community Guide
(www.thecommunityguide.org). There is a systematic method for this review; however,
there is a lack of standardized methods and reporting of economic data in the already
limited literature (Carande-Kulis et al., 2000). Policy makers are taking an interest in this
information about economic returns because of increasing budget constraints and public
concern about fiscal accountability. This will become even more of a demand as
taxpayer money is being used for Prevention Fund activities.
Policy makers need clear metrics to determine whether an intervention improves
community health and whether that intervention is worth the investment. Public health
services must demonstrate and communicate measureable contributions to the
population’s health so decision makers can have ample information when allocating
resources on the basis of effective activities (Jacobson & Neumann, 2009).
Unfortunately, not only are financial ratios and economic analyses rare in public health
systems research, but better data are needed to measure the health of communities.
Although it is not perfect, practitioners should try to use economic analysis to inform the
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decision makers as best as possible, and to provide the information before a funding or
policy decision needs to be made. Stating that the effect will occur and be measured at
some point in the future is just not sufficient in this time of economic hardship. Given
the discussion of barriers, it is understandable that public health is seen as a relatively
easy target for funding cuts. Some common reasons public health is routinely unfunded
are summarized by Bovbjerg et al. (2011):
The benefit of public health is a future benefit rather than immediate.
Public health interventions benefit the population at large rather than
individuals.
The causal pathway from public health to better health is not clear.
Public health initiatives require change that is not always popular .
There are growing opportunities to secure public health funding; however, public
health practitioners will need to build support and advocacy through value measures.
Practitioners often refer to public health as a “great investment” but are hard-pressed to
substantiate that statement with economic or financial analysis. Public health as an
investment strategy is being tested through non-traditional interventions. New creative
funding opportunities such as social impact bonds have been initiated in the UK and in
cities such as Boston and New York. Social impact bonds are performance-based
investments where the government partners with service providers and investors to fund
creative prevention and early intervention services that improve social outcomes.
Investors will require information on value, effectiveness, and return on investment prior
to committing resources. In addition, bond payment is based on performance; therefore,
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robust evaluation of outcomes as well as financial impact is critical (Callanan & Law,
2012).
Public health practitioners must start thinking like investors, making reasonable
judgments about performance and cost, even when precise return on investments cannot
be calculated (Bovbjerg et al., 2011). Simply learning to talk more like an economist is a
strategy for improving public health.
Economic Evaluation Models and Frameworks
Scientific studies of value in public health are scarce, but even less is found in the
literature examining systems or infrastructure that give context to the economic methods
used to analyze value. A public health systems intervention framework is needed to
define the inputs and outputs necessary for economic analysis, as well as to show
meaning in the economic results. However, before examining models, it is important to
define value. Jack J. Phillips (2008) gives an updated definition of value and states that
value must:
be balanced, with qualitative and quantitative data;
contain financial and non-financial perspectives;
reflect strategic and tactical issues;
satisfy all key stakeholders;
be consistent in collection and analysis.
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A framework for assessing value is a structure for gathering and organizing information
that makes it easier for practitioners, researchers, and policy makers alike to decide
whether an intervention or system change is worthwhile.
When a framework is illustrating the valuation of community-based prevention
intervention, it is important to include impacts on all members of the community and
measurements should cover the domains of health, community well-being, and
community process. An Integrated Framework for Assessing the Value of CommunityBased Prevention, developed by the Institute of Medicine, is the most recent
comprehensive text on valuation for community-based work. The IOM report (2012)
proposes four indicators to measure the value of community-based prevention: changes in
health, changes in community well-being, changes in community process, and changes in
resources used. Although there are many measures to quantify changes in health and
resources, changes in community well-being and community process are much harder to
measure. Elements of community well-being include wealth and income, education,
employment, crime, social support, etc., and can include physical as well as social
characteristics. The County Health Rankings (www.countyhealthrankings.org) begins to
measure this in a systematic way but struggles with methodological issues. Community
processes include leadership development, civic engagement, decision making, and
history and are much more difficult to quantify.
An economic assessment of value can have a prospective (such as the cost
estimates produced by the Congressional Budget Office) or retrospective design. The
chosen frameworks should keep this perspective in mind. Most program evaluations are
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concurrent or retrospective assessments of value. In addition to the timing perspective,
the IOM Committee on Valuing Community-Based, Non-Clinical Prevention Programs
(the Committee), responsible for the IOM report, concluded that a framework should
include the following elements:
A decision making context—who are the decision makers and what are they
trying to decide?
A list of valued outcomes—what do the decision makers care about? And how
do we measure each of those outcomes?
A list of admissible sources of evidence—what information does the decision
maker use to build the model of causation linking the intervention to the
outcomes?
A method for weighting and summarizing—how is information on all the
valued outcomes made understandable to the decision maker?
The Committee identified eight existing frameworks that have been used to assess the
value of community-based prevention (IOM, 2012). Some of those frameworks that go
beyond simple economic analysis include the PRECEDE-PROCEED model, the Re-AIM
framework, and Health Impact Assessment. The frameworks presented in the IOM
report are summarized here for this dissertation in Table 4.
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Table 4
Framework for Economic Evaluation
Framework

Description

Benefit-Cost Analysis

Compares all costs to all benefits in a dollar amount. Benefits
represent all perspectives, but not all benefits are easily converted to
financial value.

Cost-Effectiveness Analysis

Similar to Cost-Benefit analysis but health is the valued outcome.
Answers how much it costs to produce a health outcome. This
method is difficult for measuring community improvements.

Congressional Budget Score

Analyzes proposed legislation to provide budget and economic
information for Congress. Focus is on changes to the federal deficit.
Does not emphasize value of health improvements from communitybased prevention.

PRECEDE-PROCEED

Framework for decision making in the planning and evaluation of
health promotion and disease-prevention programs. Predisposing,
Reinforcing and Enabling Constructs in Educational Diagnosis and
Evaluation – Policy, Regulatory and Organizational Constructs in
Educational and Ecological Development. >1,000 published
applications. Dependent on local conditions and the input of
community. No assessment of resources.

Re-AIM

Reach, Effectiveness, Adoption, Implementation, and Maintenance
Framework. Used in community health promotion field to assess
whether a specific intervention is likely to have a positive health
impact. Resource use and population health are outcomes.
http://www.RE-AIM.org

Health Impact Assessment

Health Impact Assessment involves a 6 step process including
screening, scoping, assessment, recommendations, reporting, and
monitoring and evaluation and is applied to policy changes being
proposed outside the realm of health. The idea is to measure the
health impact of a policy in another discipline and report those
findings to policy makers to help inform decision making. Economic
analysis could be a part of the analysis; however the focus is on health
impacts.

Community Preventive Services
Task Force Guidelines

CSPTF is an independent, nonfederal, group appointed by the CDC.
Prioritizes topics and evaluated the effectiveness of interventions.
Don’t often analyze cost effectiveness information unless the
effective study includes substantial evidence in this area.

Canadian Health Services
Research Foundation Model

Also called the Lomas model, provides a framework for combining
evidence of different types. Doesn’t specify a list of valued
outcomes, but lists different types of evidence used by decision
makers. More descriptive model than decision aid.
(IOM, 2012)
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Although each of these models has advantages, none by itself provides a
comprehensive framework for public health system evaluation. In addition, cost-benefit
and cost-effectiveness analysis are often considered economic methods, not frameworks.
A few other models are discussed in the literature but were not included in the IOM
report on assessing value.
Results First
In the state of Washington, legislators and agencies use a research model
developed by the Results First team to help achieve better results with lower costs. The
model has been applied to create significant improvements in crime and incarceration
rates with cost savings (PEW Center on the States, 2012). The Results First cost-benefit
analysis model includes seven steps:
1. Identify effective programs from the literature for a given problem.
2. Predict the impacts of policy options being considered around the problem.
3. Calculate the potential return on investment of policy options and assess the
investment risks, based on all available research studies.
4. Rank the projected benefits, costs and risks of all programs.
5. Eliminate ineffective programs to simplify options for the policy makers.
6. Assess the combined benefits and costs if options were combined.
7. Communicate with policy makers so they understand the assessment.
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This model relies heavily on research in the literature for effectiveness studies and costbenefit analysis of interventions. Unfortunately, the literature on cost analysis in
community-based public health interventions is limited.
A similar seven-step framework was developed in Australia specific for public
health programs (Population Health Division, 2012). This model depends less on the
literature but requires a significant amount of estimating both mortality and morbidity
outcomes as well as costs and benefits of the public health program. In addition, this
framework has been developed to assess the value of a program, and is less applicable to
public health system change.
Ritzwoller Model
Ritzwoller describes a five-step process for practical cost assessment techniques
that are primarily applicable to behavioral interventions (Ritzwoller et al., 2009). In
summary, the five-steps are:
1. Determine the perspective of the analysis.
2. Identify required components if the intervention were to be duplicated.
3. Capture the cost of those replicable components.
4. Analyze data to calculate a cost per intervention or per participant.
5. Conduct sensitivity analysis to address uncertainty in the adoption of
intervention.
Although comprehensive, this framework is again geared toward specific interventions
and does not aid in the organization of data for system change. In addition, the
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framework does not address long-term behavior change or the cost savings of health
outcomes.
Economic Assessment Tool (EAT)
The Economic Assessment Tool has been designed to understand the economic
value of nursing services. This model sets up a return on investment analysis for nursing
innovations and services (Ryrie & Anderson, 2011). EAT was built on the discipline of
improvement and is based on four stages: mapping and planning, costing, calculating,
and reporting. In the first phase, analysts develop process maps and a plan for data
collection including cost measures. In the costing phase, monetary values are assigned to
all inputs and outcomes associated with the innovation being studied. Data on
effectiveness that cannot be quantified are also collected. Phase three is designed to
calculate the return on investment dividends by comparing all costs with benefits.
Importantly, phase four is included so that results are reported to decision makers.
Practical Cost Benefit Analysis (PCBA)
Recognizing the inherent shortcomings of most models and economic methods as
applied to public health interventions, this model was developed to provide simple
analysis for public health practitioners who are not entrenched in economic research
(Miller et al., 2010). The PCBA functions as a tool of break-even analysis that does not
require randomized controlled research design to provide quick and effective economic
evaluation. This model requires three steps: (1) conduct a literature review to identify
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existing evidence related to the cost studies of similar interventions to estimate benefits
associated with avoiding the health issue, (2) develop a cost model to estimate costs and
define scope, and (3) determine the magnitude of the health effect required to achieve a
favorable cost-benefit ratio.
Logic Models
If the model is to be practical and beneficial to public health, it is important to ask
practitioners what is important to them in an economic framework. When 46 public
health practitioners in four states were asked to describe potential models for measuring
the value of public health services, the respondents commented that the most promising
model would combine cost accounting methods, community assessment, and an internal
consensus-building process for setting priorities (Jacobson & Neumann, 2009). Jacobson
and Neumann suggest using logic models as a way to frame value in public health. Logic
models link expenditures to outcomes and provide context for the data and analysis.
Logic models also provide a clear pathway for decision makers and policy leaders to
understand.
Economic Methods and Measures
Once a model is developed to add structure and context to the economic analysis,
a measurement tool and economic methods should be chosen. Various texts, most
notably the CDC’s Prevention Effectiveness: A Guide to Decision Analysis and Economic
Evaluation (Haddix, Teutsch, & Corso, 2003), and web-based tutorials exist that explain
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in great detail economic methods for analysis (Drummond et al., 2005; Gold, Siegel,
Russell, & Weinstein, 1996; Muenning & Khan, 2002). The Centers for Disease Control
and Prevention has a webpage dedicated to Public Health Economics and Methods
(www.cdc.gov/stltpublichealth/pheconomics/index.html), which focuses on three specific
economic evaluations: cost-effectiveness, cost-benefit, and cost-utility analyses I
developed a summary table, Table 5, linking brief definitions, calculations, and resources
for these basic methods for this dissertation.
The CDC resource provides several links to valuable tools and reference material,
including topics beyond the scope of this research, for example, economic evaluation of
public health laws and their enforcement, and decision and transmission modeling (CDC
2013).
Public Health Uniform National Data System (PHUND$) is a web-based financial
data collection and analysis tool that has been developed and maintained by the National
Association of County and City Health Officials (NACCHO). This system is designed to
collect local public health agency financial data in a standardized, common format and
then create analysis markers for public health practitioners, such as ratio and trend
analysis (Honoré, 2012). PHUND$ provides a way for health departments to track their
financial trends in a standardized way, which allows for comparative analysis between
agencies (benchmarking) and measures of program sustainability
(http://www.publichealthfinance.org/research-and-analysis/2292).

Table 5
Economic Evaluation Options for Public Health Systems Intervention
Method

Definition

Calculation

Interpretation
Cost-Benefit Analysis
B-C
Positive number indicates
where B = incremental benefit of benefit, Higher number is
a program and C = incremental greater value
costs (money-money)

Resources

Net cost-benefit

total overall benefit
after costs are
accounted for

Cost-benefit ratio

Type of standardized
cost benefit analysis

Return on Investment
(ROI)

measure to evaluate the
efficiency of an
investment

Cost-effectiveness ratio

net cost per unit of
health gained, measures
interventions in terms of
effectiveness

Incremental costeffectiveness ratio

(ICER) compares
differences between the
costs and health
outcomes of two
interventions; used to
compare options

Cost-utility analysis

type of costeffectiveness analysis
where health benefits
are measured in years of
healthy life lived

CDC offers tools to help with cost
estimates. The Chronic Disease Cost
Calculator is a downloadable tool to
estimate costs of 6 chronic diseases.
http://www.cdc.gov/chronicdisease/res
ources/calculator/index.htm
B/C
Higher ratio is greater value, Economic Impact Analysis Tool
where B= incremental benefit of any number >1.0 has a net
developed by HRSA/Office of Rural
a program and C= incremental
benefit
Health Policy can be found on the Rural
costs (ratio)
Assistance Center website
http://www.raconline.org/
[(B-C)/C] x 100%
Positive ROI indicates
Public Health Return on Investment
where B = incremental benefit of benefit, the higher the
Tool, currently in development being
a program and C = incremental number, the higher the
Beta tested; Center for Health Care
costs (% or ratio)
benefit
Strategies, Inc. ROI evidence base and
forecasting calculator www.chcs.org
Cost-Effectiveness Analysis
C/HB
The lower the ratio the
Cost effectiveness analysis registry
where C=net costs and HB =
better the value of the
website; Guide to Analyzing the Costincremental health benefit
intervention
Effectiveness of Community Public
(money/health benefit)
Health Prevention Approaches
http://aspe.hhs.gov/health/reports/06/
cphpa/
C2-C1/HB2-HB1
The result demonstrates the Prevention Effectiveness: a guide to
where C1 and C2 are the net
additional cost per unit of
decision analysis and economic
costs of two mutually exclusive health gained with
evaluation. 2nd ed. Haddix, Teutshc,
intervention, and HB1 and HB2 intervention 2.
Corso, eds. New York, NY: Oxford :2003
are the health benefits of those
same mutually exclusive
interventions (money/health
benefit)
C/HB
lower ratios are better
A bibliometric review of costwhere C=incremental costs and values; typically values of
effectiveness analyses in the economic
HB = quality adjusted life years
$50K or $100K per QALY are and medical literature (Medical
(QALY) (money/QALY)
considered "good value" in Decision Making. Vol. 30, Issue 3, May
health but this is subjective 2010, pp 320-327)

Comments
Must be able to quantify health
benefits if those are to be
included; program approach
might be difficult to apply to
system change

Consistent measurement of
costs and benefits across PHSR
interventions is critical for
comparison and research

health benefit can be number
of people cured, # of
asymptomatic days, reduction
in glucose, etc.

Comparative effectiveness
approach
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Mortality and life expectancy are two basic measures of population health often
used to measure “health benefit” in cost-effectiveness analysis. Shorter term indicators
include measurements of self-perceived health and functional status often captured in
population health surveys such as the Behavioral Risk Factor Survey, the National Health
Interview Survey, or the National Health and Nutrition Examination Survey, and many
others (Mokdad & Remington, 2010). The CDC “Healthy Days Measures” have also
been suggested by Parrish as being the most viable option for health-related quality of life
measures (Parrish, 2010). The standard 4-item set of Healthy Days core questions (CDC
HRQOL– 4) has been used since 1993 in various surveys and is validated. It would be
almost impossible to include all health benefits of an intervention that may include longterm related social and environmental benefits.
The U.S. Public Health Service Panel on Cost-Effectiveness in Health and
Medicine has recommended the use of quality-adjusted life-years (QALYs) as the best
way to estimate outcomes in a cost-effectiveness analysis. Cost-utility analysis is the
method that uses QALYs as the measure for health benefits. QALYs take into account
both length of life and quality of life in one measure. Using this measure allows a
comparison of the dollar cost per health benefit of different interventions to be analyzed
(Bryan et al., 2009). QALYs are not easy to determine, nor are they intuitive. The
National Institute for Health and Clinical Excellence (NICE) defines the QALY as a
“measure of a person’s length of life (survival or life expectancy) weighted by a valuation
of their health-related quality of life” (www.nice.org.uk) (C. Phillips, 2009). Quality of
life valuation is called health utilities, and the EQ-5D is widely used as the instrument for
measurement. With QALYs, a year of perfect health is worth 1 and a year of less than
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perfect health is valued from 0 to 1. A small number of QALY tables of disease specific
QALY weights have been published and all but the most severe and least severe
conditions fall in the range of .7 to .9 for chronic conditions (Maciosek et al., 2001).
Partnership for Success
The local public health department stands at the center of the public health
infrastructure which represents the available capacity to carry out these services (Baker &
Koplan, 2002). Since the public health workforce represents the major component of the
public health infrastructure, it is essential to study workforce composition and
competency to determine the best system for implementation. The public health system
consists of many diverse organizations and partnerships. The IOM committee
recommends that public health departments work with other providers and agencies to
develop adequate capacity. Partnership is an effective strategy to increase capacity and
maximize efficiency and effectiveness in acquiring and using resources (Suarez et al.,
2011). In fact, public health partnerships were found to be significantly related to public
health system performance using the NPHPS Instrument (Scutchfield et al., 2004).
Agency partnerships with universities were positively associated with performance on
essential services 1, 2, 6, and 10. The core function of assessment supports and catalyzes
the other two functions of policy and assurance and is often beyond the scope of the local
public health department. Health in all policies requires a multidisciplinary approach,
which necessitates collaboration (Koh, 2011).
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Community partners aid in the public health mission by expanding funding for
public health from federal, state, and private sources. Partners in New Hampshire
provided more funds than state and federal funds dispersed by the state to the public
health department, and about half of partner spending went toward direct public health
service (Bernet, 2012).
There is little additional information on collaborative partnerships in public
health. Although collaborative partnerships are becoming an increasingly popular
strategy, especially in these times of fiscal hardship, there has been limited empirical
evidence that exists on their effectiveness in improving community-level outcomes
(Roussos & Fawcett, 2000). Noting this research gap, Zahner (2005) studied partnerships
with local public health departments in Wisconsin. She found that partnerships with local
health departments and one or more other system partners addressed 35 different primary
focus areas. The most common focus areas were tobacco prevention, maternal and child
health, emergency planning, community assessment and planning, and immunizations.
Partnership success, as measured by implementation of partnership plans, was the least
evident in “designing local health systems or services.”
As demands on public health increase, while financial resources decrease,
partnerships across disciplines are likely to rise. Unique public health system
arrangements and delivery models must be evaluated for success, both in health outcomes
and economic efficiency. The partnership between the University of Rochester Medical
Center (URMC) and the Monroe County Department of Public Health (MCDPH) has
grown over the past decade into what is known today as the Center for Community
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Health (CCH). Assessing whether the development and maintenance of the CCH is
value-adding for the University investment is the topic of this dissertation. The
partnership was developed to improve community health by adding capacity to conduct
the work of public health; however, overall evaluation of this system development has
not yet occurred in a systematic way.
Chapter Summary
Current work in public health economics is sparse but includes some promising
results. Trust for America’s Health found that every $1 spent on community-based
prevention in physical activity, nutrition, and smoking cessation efforts yields $5.60 in
health savings. Medical expenses for those who are obese have been quantified and are
much higher than normal weight persons. Mays and Smith (2011) found that mortality
rates fell between 1.1% and 6.9% for each 10% increase in public health spending. More
research in public health economics is needed, and programs and interventions must
begin evaluating their work in terms of cost-effectiveness and return on investments. My
dissertation research begins to fill this gap.
The Affordable Care Act has placed national attention on prevention and the
public health system. The ACA established a Prevention and Public Health Investment
Fund to provide for expanded and sustained national investment in prevention and public
health programs that builds up from $500 million in FY 2010 to $2 billion in FY2015 and
each fiscal year thereafter. The ACA also directed HHS/CDC to fund research in the area
of public health services and systems that examines evidence-based practices relating to
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prevention, including comparing community-based public health interventions in terms of
effectiveness and cost.
There are many barriers to public health economic analysis, including the time
frame often needed to see health effects with primary prevention. Other barriers include
the lack of randomized controlled trials in public health systems research, lack of
applicability of common economic methods in public health, and lack of expertise among
public health practitioners. Quantifying investments and subsequent outcomes in public
health is difficult and will require new models, new methods, and creative analysis.
To simplify translation in economic analysis, a framework should be used to add
context to economic methods. The Institute of Medicine (2012) provides a summary of
many frameworks in their recent report, “An Integrated Framework for Assessing the
Value of Community Based Prevention.” In addition to the frameworks described in the
IOM report, other models such as Results First, Ritzwoller framework, Economic
Assessment Tool, Practical Cost Benefit Analysis, and logic models provide options for
public health economic researchers and practitioners.
Public health systems are changing with many partners being added to the central
hub of the governmental public health department. Partners from academia, communitybased organizations, and health care systems are more frequently linking to the public
health system infrastructure. This dissertation presents one such partnership where the
University of Rochester has joined the local public health department network by
investing in the Center for Community Health. This study will analyze the investment
made by the University to the Center for Community Health in terms of value, both in
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adding to the public health capacity needed to conduct the essential services and in
financial efficiency and effectiveness.
The value of public health is measured in terms of its ability to conduct the 10
Essential Services of assessment, policy, and assurance. To date, public health leaders
have measured their value by how well they completed the essential services and their
impact on community health. Very little research has been done to assess the financial
value of public health, even though this is a growing need of policy leaders and
organizational decision makers. As the nation is searching for ways to cut costs,
prevention is emerging as a viable solution. Most research has studied clinical prevention
methods and screening, which do not usually provide cost savings, although many
provide some level of cost-efficiency and cost-effectiveness. Public health provides
potential cost savings since the work of public health concentrates on environmental and
behavioral changes, including the social determinants of health. Early primary
prevention that creates healthy environments will encourage beneficial behaviors—the
first steps to keeping people healthy and therefore away from using expensive health
services.

CHAPTER III
METHODS
Research Design
This study is a multiple-methods retrospective analysis of the value change
associated with the development and growth of the Center for Community Health (CCH),
a unique naturally occurring experiment. This is a non-experimental, longitudinal case
study of the CCH over a 6-year period. Costs and benefits are analyzed over time,
starting with the initial contribution of the University of Rochester to the Center for
Community Health in May of 2006 and continuing through June 2012. The financial
gains and losses are presented from the perspective of the University of Rochester, who
contributed the original costs for start-up of the CCH and continues to support the CCH
financially. This work does not determine costs and benefits associated with other
indirect effects related to health such as education, productivity, or absenteeism, although
obviously contributory to the economic analysis but beyond the scope of this study.
The study focuses on organizational-level changes and measures the costs and
benefits associated with the CCH and its initial and ongoing development. To date, most
economic research in public health takes either a micro-approach studying specific
interventions or specific disease states, or a macro-approach looking at national
investments in public health and overall trends in outcomes. Taking a mid-level
approach of examining a discrete departmental organization containing multiple
61
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interventions, as is done in this dissertation, contributes to the body of knowledge of
value benefit to investments in public health systems. This study collects real
observational financial data over time, as opposed to modeling or predictive analysis, to
answer the question of whether investments in public health system infrastructure as a
whole are cost-beneficial and/or offer a valuable return on the investment.
As discussed, developing a framework to add context to economic methods is
important for understanding data collection and ultimately for translation to policy
makers and practitioners. The IOM (2012) report, “An Integrated Framework for
Assessing the Value of Community Based Prevention,” lists characteristics necessary for
an effective framework, and then describes several existing frameworks that were
summarized in Chapter II of this dissertation. After reviewing the literature regarding
existing frameworks, it seems a more practical model is needed that considers the IOM
desirable characteristics and blends existing frameworks. I propose the following
Framework for Assessing Value in Public Health System Change:
Framework for Assessing Value in Public Health System Change
1. Define the analysis as prospective or retrospective; set a time frame.
2. Define the decision makers who will use the results of the analysis.
3. List the outcomes of value to the decision makers—financial and/or health.
4. Develop a logic model or system map that ties the system change or
investment to the valued results, including intermediate steps.
5. Define measures for outcomes.
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6. Collect data for each measure and assign monetary values to health outcomes
where possible.
7. Select appropriate economic method for analysis and calculate value.
8. Write the story for decision makers using the outcomes of value.
I apply this framework to the current study of the Center for Community Health and the
continuing investment made by the University of Rochester. Using the framework, this
analysis is a retrospective analysis of the Center for Community Health (CCH) and spans
the time from May 2006 through June 2012, based on the University’s July–June fiscal
year. The decision makers for this analysis are the leaders of the University of Rochester
Medical Center (URMC), and therefore the analysis is from the perspective of the
University, and whether the CCH is a value-added endeavor, worthy of significant and
continuous annual funding. The URMC has committed to community health as its 4th
mission and initiated and supported the CCH to contribute to this mission; therefore,
measure of community health improvement is a most valued outcome (Step 3).
However, decision makers need to be fiscally accountable and must be informed on
economic measures in order to make sound future funding decisions. URMC invests
substantially in the CCH and the URMC is interested in the return on that investment,
both in adding value to community health and in financial return. Therefore, a secondary
outcome measure of importance is the financial gains of the CCH, including the indirect
costs recovered by URMC via CCH. Financial solvency is critically important to
maintain the CCH, which will add to community health infrastructure, sustain the CCH
health care workforce and services, and ultimately assist in improving the health of our
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community. Assessment of public health infrastructure and service delivery is an
important and prioritized outcome, and is measured by using the Essential Services as a
guide.
A logic model that systematically represents the outcomes of the URMC
investment and assigns measures to each outcome is depicted in Figure 4. A logic model
links structure, processes, outputs, and outcomes. Health outcomes of interest can and
will change depending on the intervention or the concerns of the investor. For example,
there are several service areas that have emerged from the CCH, including cancer
services and infectious disease surveillance, and several programs including diabetes
prevention and health education, and each service area or program has specific desired
health outcomes. Taken collectively, each programmatic change resulting and an
outcome of interest contributes to the overall health of the community and could be
detectable in an overall measure of the community’s health such as the local Behavioral
Risk Factor Survey, called the Monroe County Adult Health Survey, or in morbidity or
mortality measures for the county.
As defined in the Institute of Medicine (2003) report, the ultimate health impact
for public health is to protect and promote health and well-being, and a strong national
and local governmental public health infrastructure is necessary to accomplish that goal.
Therefore, the logic model contains the intermediary step of building public health
capacity as measured by the 10 Essential Services, a well-recognized measure of public
health infrastructure and function. Measuring public health system performance—the
extent to which the system achieves its mission—requires the ability to measure each of
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the components of the system and their relationships with each other. The logic model
presented in Figure 4 is based on the conceptual framework of the public health system
developed by Handler, Issel, and Turnock (2001), which also includes the macro context
of the social, economic, and political environment in which the public health system
exists.

*Indirect Cost Recovery: As grant dollars are secured for UR through CCH efforts, a percent of the grant
award is allotted to URMC to cover the costs of doing business such as utilities, personnel, equipment, etc.
This money, in essence, partially offsets the URMC investment in CCH

Figure 4. Logic Model for URMC Investment in Center for Community Health

It is important to note that although building community health capacity should
logically lead to improved community health, this has not been demonstrated in the
literature; the assumption that capacity building leads to actual improvements in health is
not substantiated with scientific evidence. A recent study by Ingram, Scutchfield,
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Charnigo, and Riddell (2012) examined the relationship between public health system
performance in providing the core public health functions of assessment, assurance and
policy development, and community health outcomes. After studying local public health
systems covering 444 counties in 23 states, the authors found that health system
performance as measured by success in the 10 Essential Public Health Services was
associated with three of the six outcome measures—percentage of mothers receiving no
prenatal care in the first trimester, coronary heart disease, and pertussis rate—but were
not associated with the other three health outcomes—percentage of low birth weight
babies, syphilis rate, and colon cancer rates. Moreover, the associations were not always
in the predicted direction. These recent results add to two older articles examining the
same relationship. Schenck, Miller, and Richards (1995) found that high performance in
health departments, as measured by a survey of 26 indicators based on the core functions
of public health, was often associated with poor health status, which seems
counterintuitive; however, they examined primarily birth indicators as the health
outcomes, which is only a small part of public health functions. Kanarek, Stanley, and
Bialek (2006) found relationships between performance and four of the nine health status
measures they examined using the Community Health Status Indicators (CHSI).
Although these results are promising, the researchers did not report on the magnitude or
directionality of the associations they observed.
There are several reasons why it is difficult to study the relationship between
public health capacity and community health outcomes. Two of the most significant
barriers are the time lag from prevention to development of chronic disease and the lack
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of agreed-upon set of “public health outcomes” (Joly et al., 2007). Current improvements
or lack thereof in community health status may be the result of public health decisions
made years ago. Recent national accreditation may speed up the development of
community-level system outcomes that can be expected of a well-functioning health
department. Several options exist, including Healthy People 2020.
Although the association between public health capacity and community health
outcomes is still being examined, the Essential Services offer a good framework for
identifying, analyzing, and evaluating public health activities. Since their development
and release from the Institute of Medicine in 1994, the 10 Essential Public Health
Services has gained broad acceptance as evidenced by their use in national initiatives
such as the Healthy People 2010 infrastructure chapter and in the National Public Health
Performance Standards Program (NPHPSP) instruments, endorsed by the CDC, the
American Public Health Association, the National Association of County and City Health
Officers (NACCHO), and many others (Corso, Wiesner, Halverson, & Brown, 2000). It
is reasonable to assume that the extent to which a system achieves its mission depends on
that system’s performance. The mission of public health systems is to improve
community health, and the system’s performance is best measured through the 10
Essential Public Health Services; therefore, improvement in performance of the essential
services might reasonably lead to improved community health in the future.
In this dissertation research, the logic model conceptualizes the process of URMC
investment to community health impact. However, we cannot presume that the
investment in CCH would be the cause for any improvement in community health as
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measured by the Monroe County Adult Health Survey or any other broad measure of
population health without a more robust research study design. Instead, I measured the
financial implications of the investment by URMC to CCH as well as the community
health capacity change as a result of this investment, as measured by the 10 Essential
Public Health Services. I then examined one program that resulted from the development
of the CCH as a case study example of how health can be impacted by infrastructure
investment. Data and methods will be discussed in the next sections.
Study Participants
Since this is a secondary data analysis, the actual population of study participants
is quite small. Interviews were conducted with key informants at the Center for
Community Health, which includes managers and or directors that oversee the service
activities at the Center. In addition, managers and directors who have been with the CCH
since its inception were interviewed informally for historical accuracy. An interview
guide has been developed and is discussed below. Human Subjects Institutional Review
Board (HSIRB) approval was sought from Western Michigan University; however, this
study was found to be exempt from HSIRB approval.
Measurement Instruments
Both quantitative and qualitative data were collected on all aspects of CCH
depicted in the logic model. Qualitative data were collected through in-depth, openended key informant interviews to gather historical information about the start of the
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CCH and its development. Interviews were conducted with the CCH Director, Financial
Officer, Community Engagement Director, and Communications Director, all four of
whom were on staff at the initiation of the CCH. In addition, open-ended interviews
were conducted with 14 service leaders at the CCH to gather information about the ways
in which CCH services carry out the 10 Essential Services. The interview materials are
given in Appendix A. The script includes the following questions:
1. What services or programs do you provide that might be considered part of
public health system delivery?
2. After reviewing the 10 Essential Services (listed), where do you think your
programs or services fit? Name as many as you think are appropriate, and it
may be that your services do not match any of the public health 10 Essential
Services.
3. In your opinion, does your service or program area add financial value to the
University of Rochester? Please explain.
Quantitative data were collected primarily from the finance function of the CCH
and were collected from 2006 through fiscal year 2012. Economic data were gathered in
the following categories:
Revenue: What money is coming into the CCH to cover costs? Revenue falls
into two primary categories, the annual investment money from UR, and
extramural money from grants; there is no revenue from programs at CCH.
Each category was tracked over time.
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Indirect Cost Recovery: How has the CCH extramural funding in grants
contributed to URMC indirect cost recovery via CCH? As grant dollars are
secured for UR through CCH efforts, a percentage of the award is allotted to
UR to cover the costs of doing business, such as lights, accounting personnel,
etc. Indirect cost recovery was tracked over time.
Expenses: Where has the money been spent? Expenses fall primarily into
personnel expenses—wage and fringe—and rent. There are other expenses
primarily from program and service costs related to materials, travel, etc.
Expenses by category were tracked over time.
The 10 Essential Service for Public Health was used as a measurement tool for
community health capacity assessment, an intermediate step to health impacts. Services
that are delivered through the Center for Community Health were matched to essential
services that they provide, and any uncertainties were discussed with the program
manager. There are 14 program and/or service areas that were studied and outputs or
process measures were categorized by essential service. At the end of the analysis a
complete picture of how the Center for Community health currently contributes to the
assessment, policy, and assurance of the public’s health is summarized. For example, a
few clear examples of how the 10 Essential Services are fulfilled through work within the
CCH are described below:
#1. Monitoring health status: The development of the CCH has supported the
growth of the Communicable Diseases Surveillance and Prevention program,
which includes emerging infections and health care associated infections
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prevention. By developing the infrastructure to monitor public health
communicable diseases, we have been able to standardize protocols, target
interventions, and impact health—in this example by decreasing infections in
hospitals as closely tracked by the emerging infections director and the CDC.
#4. Community partnerships: How many partnerships were in place at the CCH
inception? What partnerships and partnership networks exist currently and at
each year in between? Partnerships include clinical practices, community-based
organizations, academic centers, research networks, etc.
#8. Competent workforce: One key function of the CCH being housed in an
academic medical center is to contribute to the education of students from all
disciplines. Faculty within the CCH educate medical students, nursing students,
public health students, and undergraduates, among others, on the principles and
practice of community health.
Procedures
To analyze value changes over time since the initial investment of URMC,
financial information was collected from the finance office at CCH. Meetings with the
accountant and finance director took place to explain the study and to request
information. Data were included for income from 2006-2012 categorized by source,
expenses for the same time period by category, indirect cost collected per year, and
number of full time equivalents in personnel over time.

72
Descriptions of programs and services performed by the faculty and staff at CCH
were reviewed and categorized into the most appropriate 10 Essential Services. After
initial categorization, I met with each service/program area director to discuss my
thoughts and acquire feedback, which was incorporated as appropriate.
For each of the many program areas or services provided at the CCH, one could
track all possible benefits both in short-term health outcomes and in community-wide
health impacts; to do so would be quite expansive and resource intensive, and beyond the
scope of this dissertation. The primary services and programs provided by the CCH are
listed below:
Healthy Living Program
Diabetes Prevention Program
Community Transformation Grant – H.E.A.R.T.
Blood Pressure Advocacy Program
Communicable Diseases Surveillance and Prevention
Teen Success and Empowerment Program
Healthy Hero
Cancer Services
Rochester Walks
Healthy Living Program
Community Health Policy
Community Health Education
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Got Health! Health Promotion and Education
Community Engagement
One service area was assessed as a case study for a more in-depth analysis of
health impact and cost-effectiveness, with the understanding that if all service areas were
assessed to impact, CCH leadership could create a picture of the total health impact and
economic effect of the URMC investment. In addition, service areas could be compared
for cost-effectiveness, if all assessment was done in a standardized fashion. An entire
analysis of all 14 services is beyond the scope of this dissertation.
Case Study
One very recently developed program at the CCH would not have been possible
to implement at the local health department due to the need for quick hire of employees,
collaboration with clinical settings, and expedited contract negotiations with local
business. This program, the Blood Pressure Advocacy Program (BPAP), was assessed
for health impact. BPAP has a current evaluation process in place, which is tracking
results that will be gathered for this study, and effects of blood pressure control have been
researched in the literature, lending this program to an anticipated straightforward
assessment of cost-effectiveness. This is a grant-funded program that uses community
health advocates to address social and behavioral determinants of health in clinic patients
with uncontrolled diagnosed high blood pressure. Data were collected for this analysis as
well, building on the data collected for the general assessment of the CCH. The total
number of clients in the intervention was analyzed, as well as the number of clients who
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have their blood pressure in control at the completion of their intervention. The literature
was studied to assess the added cost associated with uncontrolled high blood pressure,
and the projected care costs of stroke and heart attack, both common consequences of
uncontrolled high blood pressure that are averted if the BPAP program achieves client
control. Discussions with the BPAP Director and with the CCH Director and Financial
Officer assured accurate information.
Analysis Plans
Once the quantitative and qualitative data were collected, economic analysis was
performed in order to answer the research question:
Does the University of Rochester’s investment in the development and
maintenance of the Center for Community Health, a partnership extension of the
local public health system, provide a value benefit either financially or in the
health of the community?
First, revenue and costs to the CCH, as well as URMC indirect costs collected,
were graphed over time to provide a visual representation of financial change based on
investments. Other calculations were made for each year, and tracked over time. These
include:
Ratio of (indirect cost collected/UR support)
Ratio of (UR support/total budget)

100%

100%

Cost effectiveness ratio of workforce = UR support/# CCH employees
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Overall Return on Investment (net benefit of investment/cost

100%) for the

creation and maintenance of the CCH and the BPAP program
In addition, infrastructure changes were summarized for year one, FY2006, of the CCH
and FY2012 for comparison. Community health impacts that were discovered through
the review of services were listed, and cost-effectiveness of the BPAP program was
assessed.
The final step of the framework is to summarize the analysis in terms of the
decision maker. The study is to provide information to the URMC leadership regarding
the value change resulting from the URMC investments. This report includes both
quantitative statements including the results of the analysis, and qualitative discussions
regarding how the investment in the CCH has impacted the ability to provide the 10
Essential Services, building the capacity to improve community health, a pillar of the
URMC mission. In addition, a case study analysis of concrete health outcomes and the
associated return on investment was included in the report, remembering that the BPAP
program is only one of a dozen programs with quantifiable health outcomes.
Methodologic Limitations
There are several methodological limitations to this study. This is not a
randomized-control trial but rather a retrospective observational study of one system’s
experiences that can be applied to other systems as appropriate. Being retrospective and
observational, reliability of the historical data is only as strong as the key informants who
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are interviewed. In addition, in using a newly developed framework for assessment, there
may be some information inadvertently omitted.
When assessing each CCH program for its contributions to the 10 Essential Public
Health Services, the data are dependent on the manager’s or supervisor’s knowledge of
the services provided and honesty in reporting only those services provided. This
information is subject to social desirability bias, which may lead informants to overstate
compliance. This was minimalized by having the researcher also categorize the services
for comparison and discussion with the managers.
There is a substantial limitation in the inability to accurately measure community
health impact caused by the URMC investment in the development and growth of the
CCH. Causation is extremely difficult to demonstrate in the best of circumstances, and
given the added complications of time lag with prevention efforts and inconsistency in
appropriate health outcomes, is not possible in this study. I measured improvement in
community health capacity through the essential services; however, evidence is
insufficient to prove that public health capacity is associated with improved community
health outcomes.
Since this is an economic analysis, there are added limitations with the financial
data. Information is collected in very general categories, and some financial information
collection or categorization procedures may have changed over the 6-year time frame of
this study. In addition, there are many financial returns that are beyond the scope of this
study, such as those related to improved social circumstance, or improved productivity of
clients impacted by the CCH. In addition, in-kind contributions are often given to the
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CCH in the form of volunteers or student work. Since this information has not been
accurately tracked across the 6-year time span, I did not quantify in-kind contributions.
However, where such contributions are known and are substantial, in-kind contributions
were noted in narrative form.
Chapter Summary
Economic analysis is rare in public health systems research, especially at the
system level and with actual data. A framework is presented to guide the analysis for this
work as well as for the growing population of future practitioners and researchers
interested in this work. A multiple-methods retrospective analysis of the value change
associated with the development and maintenance of the Center for Community Health
(CCH), a unique naturally occurring experiment, was conducted. This is a nonexperimental, longitudinal case study of the CCH over a 6-year period. Economic
methods were used to measure value returned on the investment that URMC continues to
make in the CCH. Results were summarized and disseminated to decision makers at
URMC to inform future funding decisions.

CHAPTER IV
RESULTS
Research Questions
The research question for this dissertation work asks if investing in public health
system capacity provides value, and whether that value change be quantified in economic
terms. More specifically:
Does the University of Rochester’s investment in the development and
maintenance of the Center for Community Health, a partnership extension of the
local public health system, provide a value benefit either financially or in the
health of the community?
This work will add to the evidence-based related to questions from the Public
Health Services and Systems Research (PHSSR) National Research Agenda for public
health financing and economics, specifically, testing measures to provide valid and
reliable indicators of the financial performance of public health organizations, and
studying investments in public health and their influence on the need for downstream
spending on medical care and/or social services.
A multiple-methods retrospective analysis of the value change associated with the
development and growth of the Center for Community Health (CCH) was conducted.
This longitudinal case study of the CCH involved costs and benefits as well as growth in
community health capacity over a 6-year period starting with the initial contribution of
78
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the University of Rochester to the Center for Community Health in May of 2006 and
continuing through June 2012.
Analysis
Both quantitative and qualitative data were collected and analyzed as described in
Chapter III: Methods, and in accordance with the Framework for Assessing Value in
Public Health System Change, Step 6: Collect data for each measure and assign monetary
values to health outcomes where possible, and Step 7: Pick appropriate economic
methods for analysis and calculate value.
Quantitative Data
After acquiring approval from the CCH director and financial officer to collect
and analyze financial data for the purposes of this study, information was requested from
the CCH accountant and current finance director. Information on revenue by source,
indirect costs collected by URMC, expenses by general categories, and funds provided
through contracts or agreements to community organizations was requested for FY06
through FY11 (Fiscal Year is July1 – June 30). In addition, the number of full-time
equivalents in personnel over the same time frame was requested.
Revenue. Revenue to the CCH comes from two sources: supportive funds for
infrastructure given by the URMC each year since the CCH inception in 2006, and
extramural awards including grants, contracts, and other funding arrangements from
external sources. Information about revenue for each year from FY2006 (July 1, 2005 –
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June 30, 2006) to FY2013 (July 1, 2012 – June 30, 2013) was collected from the finance
director. Extramural award funding information was collected from the URMC
accounting website, accessed by the finance director, while URMC internal funding
information was collected from historical accounting records within the CCH (see Table
6).
Table 6
Funding Sources for the Center for Community Health FY06–FY11
Source

FY06

FY07

FY08

FY09

FY10

FY11

FY12

UR
Support

$79,800

$822,450

$825,600

$846,800

$808,800

$864,800

$887,450

Total
Awards

$12,943

$360,937

$1,748,383

$2,410,128

$3,125,257

$3,598,153

$4,577,375

Total
Funding

$92,743

$1,183,387

$2,573,983

$3,256,928

$3,934,057

$4,462,953

$5,464,825

Support from the University of Rochester has remained steady throughout the
history of the CCH, although the first year’s funding was lower. This was most likely
due to transition funding strategies, from the CCH preceding organization called the
Center for Rochester’s Health to the current structure, in addition to the FY06 including
only the months from May 2006 when the CCH opened to the end of the fiscal year (June
30, 2006). Although UR support has remained constant, extramural funding has
increased each year. Graphic representation is given in Figure 5.
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Center for Community Health Funding
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Figure 5. Funding for the Center for Community Health, FY06–FY12

The return on investment (ROI) analysis is a form of cost-benefit analysis that
measures the cost of an intervention compared to the expected financial return of the
intervention. The cost to the University of Rochester is its annual investment in the CCH
each year. One return on that investment is the extramural funding that the CCH (a
Center within UR) has been able to acquire based on that investment. The extramural
awards have been expended as “costs” and have not been returned to the UR other than
the indirect cost recovery to UR through CCH from the awards. In addition, the
extramural awards are intended to result in break-even funding, and not to yield a profit;
therefore, financial gain on the UR investment will not be quantitatively achieved until
the economic benefit of prevention of disease is quantified. However, extramural funds
contribute to the UR return on investment since the “costs” have been used to contribute
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to the mission of improving the community’s health, as was the intent of the investment
and as described in the qualitative section. For the first complete year of the CCH, the
ROI was 44%, meaning for the UR investment, the CCH was able to acquire 44% in
extramural funding. By the last complete year of the CCH, the ROI was 516%; for the
UR investment made in FY2012 ($887,450), the CCH was able to gain 516% of that
investment, an additional $4,577,375.
Another way to calculate this return is to look at the investment as a percentage of
the entire funding for the CCH, represented in Figure 6.

% Total Funds

Investment as % of Total Funds
100.0%

$6,000

80.0%

$5,000
$4,000

60.0%

$3,000

40.0%

$2,000

20.0%
0.0%
TOTAL FUNDING ($1000's)
Investment as % of Total
Funds

$1,000
FY06
$93

FY07

FY08

FY09

FY10

FY11

FY12

$0

$1,183 $2,574 $3,257 $3,934 $4,463 5,465

85.8% 69.5% 32.1% 26.0% 20.6% 19.4% 16.2%

Figure 6. University of Rochester Investment as a Percent of Total Funds for the Center
for Community Health

The ratio of UR support/total budget

100% is the investment as a percentage of

total funds. This ratio decreases each year since the inception of the CCH. The closer
this ratio is to zero, the less dependent the CCH is on UR support resources.
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Extramural funding, external to the UR, comes from several sources including
federal agencies, most often the Centers for Disease Control and Prevention (CDC) and
the National Institutes of Health (NIH), state agencies such as the New York State
Department of Health, and locally, including the Greater Rochester Health Foundation as
well as funding from other hospital systems and organizations. Extramural awards were
retrieved from the UR funding database. Awards were listed in the database by budget
period, which varied for each grant and often crossed more than one fiscal year. Each
grant was examined and funding divided into the fiscal year that most accurately
reflected the distribution. For example if an award budget period was listed as
01/01/2010 – 12/31/2010, half of the funding was categorized as FY2010 funding, and
half was categorized as FY2011 funding. Distribution of extramural funding is shown in
Figure 7.

Funding by Source Category
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$1,000,000
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$134,666
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Figure 7. Summary of Center for Community Health Extramural Awards
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Figure 7 shows that the distribution from funding sources has changed since the
inception of the Center for Community Health. Federal funding has increased
significantly over the years and for FY12 accounts for 53% of extramural funding.
City/County funding decreased for FY12 and this is due to the transfer of the School
Based Influenza Vaccine program from the CCH to the Monroe County Department of
Public Health. This program contributed $346,920 in FY11 and ended for FY2012.
Extramural funding is particularly important to the University of Rochester
because often when funding is awarded, indirect costs can often be allocated and the
indirect funds go to the University, not to the CCH. Indirect costs are used for
institutional expenses that are incurred for multiple or shared projects and activities and
therefore cannot be specifically identified with relative ease and with a high degree of
accuracy to one particular grant-funded project or account. Typical indirect costs
include:
Depreciation, maintenance, and utilities for University buildings and
equipment;
Administrative effort of clerical, faculty, and other professional personnel;
Expenses for offices which serve the entire University, such as the President’s
Office, Human Resources, Purchasing, and Finance;
Central operations such as facilities management, telecommunications,
sponsored projects administration, and libraries.
Not all grants will allow for indirect cost recovery. A summary of the indirect funds to
the University from grants and awards to the CCH is shown in Figure 8.
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Indirect Costs
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Figure 8. Indirect Cost Recovery to UR from Center for Community Health Awards

Indirect cost recovery grew substantially in the first five fiscal years then
decreased in FY12, again due to the elimination of the School Based Influenza Vaccine
program in FY12. The goal over time is for indirect cost recovery to exceed the UR
support funds and the UR sets a goal of support funds being one third of the indirect
funds collected.
In addition to the funding streams mentioned above, the CCH is responsible for
managing funds assigned to other Centers and Departments. The most substantial
example of this is the Clinical and Translational Science Institute (CTSI), which is the
institute within URMC that houses the NIH Clinical and Translational Science Award
(CTSA). URMC was one of the initial 12 academic institutions awarded in the initial
year of funding, in June 2012. The CTSA institutions work to transform the environment
to increase the speed and success of clinical and translational research. Translation of
research requires strong relationships with community—the academic community,
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practice community, and the public health community. Communication channels with
the community are built through the Community Engagement function, which is
administered through the Center for Community Health. The CCH receives funding to
complete the Community Engagement function, which improves research by basing
study questions on true community needs, and improves public health by translating
research to implementable best practices. The CCH adds value to the URMC by serving
in the Community Engagement Function. The CCH is responsible for annual NIH CTSI
funding as seen in Table 7. This funding has remained stable for the six years that the
CTSI has been operational and contributes to the public health capacity building and
employee growth of the CCH.

Table 7
UR Clinical and Translational Science Institute Funding for Community Engagement
FY07
CTSI –
$289,631
Community Engagement

FY08

FY09

FY10

FY11

FY12

$370,410

$351,891

$368,781

$317,872

$338,824

Expenses. Expenses for the CCH are only tracked collectively for the core or
operating budget, which is supported by the funds from the University of Rochester, and
not for the extramural funding. Expenses for the years since the CCH’s inception are
given in Table 8.

Table 8
Operating Expenses for the Center for Community Health, FY06–FY12
Fiscal Year
Salary
Benefits
Travel & Conference
Supplies
Lease/Rentals
Communications
Printing
Utilities
Capital Equipment
Professional Services
Misc. Expenses
Expense Credits
Total

$
$
$
$
$
$
$
$
$
$
$
$
$

2006
42,356
16,358
1,800
2,000
1,210
158
1,000
2,046
2,000
68,928

$
$
$
$
$
$
$
$
$
$
$
$
$

2007
437,397
104,194
21,015
11,099
7,350
3,992
2,105
1,354
8,981
4,290
53,574
655,351

$
$
$
$
$
$
$
$
$
$
$
$
$

2008
553,888
136,368
25,055
7,863
10,834
4,041
1,432
14,356
398
4,555
62,696
821,486

$
$
$
$
$
$
$
$
$
$
$
$
$

2009
565,191
146,280
33,690
12,528
88,369
15,332
5,193
17,369
4,416
12,473
9,812
(85,324)
825,329

$
$
$
$
$
$
$
$
$
$
$
$
$

2010
400,400
98,890
21,298
57,484
79,266
24,806
15,538
4,936
2,122
80
18,558
83,817
807,195

$
$
$
$
$
$
$
$
$
$
$
$
$

2011
521,962
136,772
29,690
29,024
122,259
18,996
9,665
11,463
1,110
7,391
(39,896)
848,436

$
$
$
$
$
$
$
$
$
$
$
$
$

2012
504,321
153,605
48,470
42,660
49,157
30,973
11,202
9,684
12,416
1,280
8,028
(23,451)
848,345
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Of note is the Lease/Rentals category. The CCH decided in 2009 to move from
the URMC building to a location within the community. The current location of the CCH
is within a historical building on the original CCH campus located in the art district of the
city. The building is easy to find and easily accessible to the public with free parking.
The CCH is open for public use including the conference rooms, the kitchen area, and the
library.
Although the operational funding for wage (salary) and fringe (benefits) has
remained relatively constant in the operating budget, the staff at CCH has grown over the
years through extramural funding. Employee numbers were tracked by reviewing the
URMC staff listings from the human resources department over the years. Employees
that joined the CCH within the FY were included as “employees entered” and those that
were terminated or retired on a date falling within the fiscal year were counted as
“employees exited.” Employee counts for each fiscal year are shown in Table 9.

Table 9
Center for Community Health Employee Changes, FY06–FY11
Employees

FY06

FY07

FY08

FY09

Number of Employees Entered

17

11

9

19

19

22

25

Number of Employees Exited

4

3

2

5

10

23

12

Total Number of Employees

13

21

28

42

51

50

63

Total #FTE* that Entered

15.60

6.90

7.75

9.94

13.95

9.65

11.25

1

1

1.50

5.44

14.65

1.75

33.69

42.20

37.20

46.70

Total #FTE that Exited
Total #FTEs
*FTE = Full-Time Equivalent

3
12.60

18.50

25.25

FY10

FY11

FY12
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The number of employees and number of full-time equivalents (FTE) have
followed a positive trajectory since the CCH opened in FY06 with the exception of
FY11, which shows a decrease in both employees and full-time equivalents. The
discrepancy between the number of employees and the number of FTEs lies in the fact
that some employees are part-time employees, and others are hired as TAR or “Time as
Recorded.” TAR employees work less than 0.25 FTE and their hours vary each pay
period. Often fellows or students are included in this category. The growing number of
employees and FTEs are shown graphically in Figure 9.

Number of Employees

Center for Community Health Faculty/Staff
70
60
50
40
30
20
10
0

Total number of Employees
Total #FTEs

FY06

FY07

FY08

FY09

FY10

FY11

FY12

13

21

28

42

51

50

63

12.6

18.5

25.25

33.69

42.2

37.2

46.7

Figure 9. Center for Community Health Employees, FY06–FY12

The CCH workforce has increased over the years, despite the relatively level
funding from UR. The CCH has been able to increase the number of people working in
community health primarily by adding staff through intramural funding.
Through the UR support funding, the CCH has been able to grow financially by
acquiring extramural funding. Much of the extramural funding is given back to the
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community to build the capacity of the entire public health system. Funding to
community organizations has grown over the years; however, these data have not been
tracked since the CCH start. The most recent fiscal year was examined for contracts with
community agencies, and the funds shown in Table 10 were contracted to community
agencies.

Table 10
FY12 Center for Community Health Funds Supporting Community Agencies
Community Agency

Amount of Funding

H.E.A.R.T. CDC Community Transformation Grant

$

320,332

Diabetes Prevention Program

$

68,000

Livingston/Wyoming Health Partnership

$

16,689

Livingston/Wyoming Health Partnership – Infrastructure

$

123,231

Livingston/Wyoming Health Partnership – COLA

$

9,883

Rochester Walks

$

30,500

Total

$

568,635

Qualitative Data
An application to the Human Subjects Institutional Review Board (HSIRB) of
Western Michigan University was submitted and assurance was granted this information
gathering process was exempt from needing HSIRB approval. Requests for a 15–30
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minute interview were emailed to all program managers and directors for the following
service areas and programs:
Healthy Living Program
Diabetes Prevention Program
Community Transformation Grant – H.E.A.R.T.
Blood Pressure Advocacy Program
Communicable Diseases Surveillance and Prevention
Teen Success and Empowerment Program
Healthy Hero
Cancer Services
Rochester Walks
Healthy Living Program
Community Health Policy
Community Health Education
Got Health! Health Promotion and Education
Community Engagement
Information for each program was gathered from any CCH-approved promotional
material, relevant and accurate website descriptions, and manager/director interview to
compile brief summary descriptions of each, which are listed in Table 11. Interviews
were conducted over a three-day period and each interview was between 15 and 30
minutes long. Notes were taken during the interview that were jointly approved as
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written. Both the researcher and the program manager/director reviewed and approved
the program description included in Table 11. More extensive descriptions can be found
on most of the programs and services listed on the Center for Community Health website:
http://www.urmc.rochester.edu/community-health.
Table 11
Programs and Services at the Center for Community Health
Program/Service Area

Description

Blood Pressure Advocacy
Program (BPAP)

This is a clinic-based program designed to help adults diagnosed with high
blood pressure get their blood pressure under control by making positive and
permanent changes in their behavior and lifestyle. The program is part of the
community-wide High Blood Pressure Collaborative.
The program is delivered by Community Health Advocates who are
community members who may not have extensive health training. The
advocates are trained to work one-on-one with patients, most of whom are
referred by patients’ health care providers. Patients can also request to meet
with an advocate on their own. The services are FREE for patients.

Breast Health Awareness
Project (BHAP)

This is an initiative of the Cancer Services Program of Monroe County. Its
focus is on educating and encouraging good breast health among women in
Monroe County ages forty and over at average or increased risk for breast
cancer and ages thirty to thirty-nine at increased risk for breast cancer. BHAP
reaches women who have health insurance but have not received a
mammogram in two or more years, to encourage them to get breast cancer
screenings.

Cancer Services Program
(CSP)

The Cancer Services Program is part of a larger statewide initiative run by the
NYS Department of Health’s Cancer Services Program. This initiative is
focused on increasing the rates of cancer screenings among priority
populations. The program covers the cost of breast, cervical and colorectal
cancer screenings for uninsured women age 40 and older and uninsured men
age 50 and older. The program is a unique partnership with over 40
community based agencies and 100 health care providers in Monroe County.
Case management is also available for those needing additional support and
assistance as they go through diagnosis and treatment.
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Table 11—Continued

Program/Service Area

Description

Clinical and Translational
Science Institute (CTSI)

The University of Rochester Clinical and Translational Science Institute
facilitates the application of basic science findings to human health problems,
developing clinical solutions, testing efficacy, and implementing
interventions at the community level. The transformation of biomedical
research requires the development of a true continuum from bench to
community. Communication and collaboration among the major sectors of
the health community – the academic community, the practice community,
and the public health community—are essential to improve the community’s
health and overall quality of life. The CCH serves as the Community
Engagement function of the CTSI and houses the Practice Based Research
Network.

Communicable Diseases
Surveillance and Prevention

This service area is part of a national effort to provide population-based
communicable disease data for surveillance of disease patterns, evaluation of
vaccine programs and to identify populations at risk for severe infection and
those in need of screening and preventive care. The service area is a
collaborative with the CDC in the 10-state Emerging Infection Program and
in collaboration with the NYS Dept of Health. This service area also
coordinates two citywide collaborative efforts working to reduce hospital
acquired infections.

Community Engagement

The CTSI Community Engagement function, by facilitating communication
and genuine partnerships among investigators, health care providers, and
community members fosters community partnership. The Community
Engagement function contributes to a more active clinical and translational
research environment and greater participation by the local community.
Community Partnership: Strengthening existing relationships and activating
new partnerships between the university, local coalitions and community
based organization are the goals of community partnership. With a focus on
prevention and the promotion of healthy lifestyles, we are working to change
the environments in which people live, work, learn and play.
Coalitions: The Community Advisory Council (CAC) was created in 2006 to
represent the voice of the community and serve as an advisory group. The
CCH serves an important role on the African American Health Coalition and
the Latino Health Coalition and many unique community coalitions.
Sentinel Network: UR is part of this group of 5 CTSA sites that survey
concerns and needs of underrepresented populations to give them a voice in
research. CCH has engaged in this discovery for several years to improve
bidirectional communication of community residents and investigators and to
link people to needed medical and social services.
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Table 11—Continued
Program/Service Area

Description

Community Health
Education

The Center supports community health learning through many activities
including mentoring students from undergrad through residency, planning
and producing Public Health Grand Rounds, supporting faculty who are
engaged in community health research and experiential learning. The CCH
teaching medical students community health and directs each student through
a one month community improvement project. Public Health Grand Rounds
facilitate the exchange of best practices through year-round presentations
from community and academic public health professionals.

Community Health Policy

The CCH informs policy decisions, both internal and external to the
University of Rochester, through community assessment, research and
intervention evaluation, to prevent disease, promote an optimal quality of life
for all, and protect the health of the community. We participate in many
policy coalitions in Rochester including PlayBest and HealthiKids that
advocate for policies that encourage healthy behaviors, as well as the Health
Impact Assessment Learning Collaborative that explores health in all
policies. We facilitate the community benefits reporting of health needs
assessment and improvement planning for hospital systems in Monroe
County and evaluate promising new programs for policy improvement. Past
initiatives have included passing an innovative lead law and promoting adult
immunization.

Community Transformation
Grant – H.E.A.R.T

In partnership with the Monroe County Department of Public Health, and
numerous community partners, the CCH was awarded a five-year, $3.6
million grant by the CDC to fund H.E.A.R.T. (Health Engagement and
Action for Rochester’s Transformation), an initiative to improve the health of
area residents through policy and environmental changes. Focus areas for
health improvement include active transportation, baby-friendly initiatives
related to breastfeeding, school health and wellness, workplace wellness, and
crime prevention through environmental design. Initiatives will also be
launched to advance diabetes prevention, self-sustaining food hubs,
management of high blood pressure, and smoke-free policies
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Table 11—Continued
Program/Service Area

Description

Diabetes Prevention
Program (DPP)

Diabetes Prevention Program (DPP) helps people who have been diagnosed
with pre-diabetes. The DPP is a lifestyle change program funded through the
Greater Rochester Health Foundation, which is offered on an individual basis
or in small sessions. In this 22-week program, participants learn about what
contributes to and gets in the way of behavior change. The program teaches
clients how to eat healthy at home and in restaurants, become active as a way
of life, reduce stress, and stay motivated.
The Diabetes Prevention Program has been scientifically validated for its
ability to help people lose weight. Current research is being conducted to help
determine the best way to provide the Diabetes Prevention Program
intervention at a reasonable cost. Through our research, we hope to identify
an effective way to delay diabetes, helping to extend people’s lives, reduce
medical costs, and improve quality of life.

Got Health!

The Center sponsors free health talks called “Got Health?” to help
community members get and stay healthy. The talks cover basic health
information and are delivered in easy-to-understand language, with plenty of
time for questions and answers. They take place in community settings, such
as places of worship, recreation centers, and libraries.

Healthy Hero Outreach
Program (HHOP)

The Healthy Hero Outreach Project supports the Greater Rochester Health
Foundation 5-2-1-0 campaign to prevent childhood obesity. The program
offers hands-on activity sessions to give families ideas for building healthy
eating and active play into their routines in easy, affordable, fun ways.
A team of outreach volunteers provides interactive presentations that focus on
the popular “5-2-1-0 Be A Healthy Hero” campaign, specifically targeting
diverse populations living in the City of Rochester and selected suburbs
where the incidence of childhood obesity is the highest in Monroe County.
The HHOP’s primary focus is to use fun, skill-building activity sessions that
include affordable recipes, safe cooking practices, and easy low- or no-cost
active play ideas to teach parents and families how to make healthy changes
at home.
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Table 11—Continued
Program/Service Area

Description

Healthy Living Center
(HLC)

Located within the Center for Community Health, the Healthy Living Center
helps patients make healthy changes in their life to lose or maintain weight,
improve diet and nutrition, lower blood pressure, lower cholesterol, reduce
stress, or stop smoking. Counseling relies on Self-Determination Theory—a
theory of motivation. It specifically defines the motives that fuel people’s
behavior and it also defines how the social environment can support or
undermine people’s motivation. Treatment is provided through individual
counseling and/or group support.
The Healthy Living Research Center is the research arm of the Healthy
Living Center. Translational research is conducted to understand the
motivational and psychological mechanisms that drive health behavior
change.

Healthy Living Program
(HLP)

Healthy Living Program/Vida en Salud: The Healthy Living Program and its
Latino counterpart (Vida en Salud) are community-based fitness and health
education programs aimed at helping African –American and Latinos adopt
healthy lifestyles. The programs emphasize physical activity and healthy
eating. They are run in partnership with the YMCA in local churches and
community organizations.

Practice Based Research
Network (PBRN)

The Greater Rochester-PBRN (GR-PBRN) was established in 2007 to bring
together primary care clinicians and researchers in a collaborative model
designed to improve patient care and outcomes. The PBRN offers
consultation on conducting practice-based research including linking
researchers and community practices, IRB assistance, protocol development,
and training for investigators and research staff in building and maintaining
practice relationships.

Rochester Walks

Rochester Walks is a grant funded program to promote walking and physical
activity in city neighborhoods. With a grant from the New York State
Department of Health, Rochester Walks! is advocating for environmental
improvements that promote walking, labeling safe and interesting walking
routes, and establishing walking clubs to bring neighbors together for fun and
fitness.
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Table 11—Continued
Program/Service Area
Teen Health and Success
Partnership

Description
The URMC Teen Health and Success Partnership works with Hillside WorkScholarship Connection (HW-SC), a nationally recognized youth
development program. HW-SC increases graduation rates within the
Rochester City School District. The University of Rochester (UR) offers
employment opportunities for the young adults who are part of the HW-SC
program.
This partnership provides opportunities for Rochester's youth to develop
hands-on job skills, while at the same time laying the foundation for future
employment and career development within health care, research, and
academic settings. The partnership provides academic resources, life skills
development, and job training including free tutoring, career shadowing,
monthly enrichment learning sessions, college preparation, wellness
programs and career coaching.
Mentoring Males on a Continuum is taking best practices from the Minority
Male Education literature and the Black Parenting literature and providing
mentorship and education to Rochester’s male teens to promote healthy
behaviors and academic success.
Be Healthy Be Successful is a health literacy and health care resource
connection program for Rochester’s urban youth. Teens attend a health
literacy seminar where they are engaged in learning to traverse the health care
system. Teens requesting assistance are linked to health insurance, medical,
dental and vision services.

The 10 Essential Public Health Services were discussed and explained during
each manager/director interview and both the researcher and the program
manager/director categorized the functions performed in that area with any and all
appropriate essential services. Several descriptions were available for the
managers/directors to review when clarity of the essential service was needed, including
the National Public Health Performance Standards Program Orientation to the Essential
Public Health Services (http://www.cdc.gov/nphpsp/documents/
EssentialServicesPresentation.pdf). After interviews were completed, all contributions to
the 10 Essential Public Health Services were compiled and summarized in Figure 10.
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ASSESSMENT
1. Monitor health status to identify and solve community health problems.
a. Communicable Disease Surveillance monitors communicable diseases, hospital
acquired infections and emerging infections for Monroe County.
b. CH Policy assists with the Monroe County Adult Health Survey to assess risk behavior
and community input on the data through the Health Action process.
c. CH Policy facilitates the Monroe County Community Health Needs Assessment for
hospital systems and the health department, for NY and IRS reporting.
d. HEART financially supports the Monroe County Adult Health Survey to monitor
behavior risk factors, and supports analysis of the data collected.
e. Healthy Living Center works with School of Nursing at URMC to aggregate and
analyze the data from the employee biometric screenings to monitor the health status of
the University employees and plan programs based on that assessment.
f. TEEN HSP monitors the progress and success of their students including academic
achievements and some health outcomes.
2. Diagnose and investigate health problems and health hazards in the community.
a. Communicable Disease Surveillance investigates hospital acquired infections and
propose interventions to reduces incidence.
b. Communicable Disease Surveillance Emerging Infections Program reports all data to
the CDC for evaluation of vaccine effectiveness and policy recommendations.
c. Community Partnerships, with the AA and Latino health coalitions, have advanced the
health agenda and strategic plan based on community health data for these
underrepresented populations.
d. Rochester Walks links with community members to evaluate communities for
walkability.
e. TEEN HSP investigates prevalent health problems such as teen pregnancy and sexually
transmitted diseases and devises interventions that are geared towards the target
population.
3. Inform, educate and empower people about health issues.
a. The BPAP program works with hypertensive patients to teach them about their blood
pressure, as well as causes and prevention of further disease through one-on-one
discussion sessions.
b. Breast Health Advocates meet with community groups to discuss the importance of
mammograms .
c. Cancer Services raise awareness of risky behaviors and teach the importance of cancer
screening through community fairs and events.
d. The Got Health! series provides basic health information to community members
through interactive lectures in community settings.
e. The Healthy Living Library is open to the public and provides books, pamphlets,
displays and community interface for access to trusted health information.
f. CH Education supports many health lectures to the URMC community and supports the
year round Public Health Grand Rounds.
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g. Communicable Disease Surveillance reports weekly to Monroe County Department of
Health during flu season so that the health department can report to the public and
advise on flu outbreaks.
h. HEART teaches healthy lifestyles through diabetes prevention and blood pressure
ambassador program and virtual clinician initiative.
i. HEART provides community screening on public health issues such as Weight of the
Nation viewings.
j. The Diabetes Prevention Program, either directly or through trained facilitators,
educates community members about diabetes prevention.
k. Healthy Hero teaches families healthy eating and exercise to prevent childhood obesity.
l. Healthy Living Program educates the community about healthy lifestyles and teaches
about activities and nutrition.
m. TEEN HSP conducts monthly enrichment health education sessions to inform teens on
health issues.
POLICY
4. Mobilize community partnerships and action to identify and solve health problems.
a. The BPAP program partners primary provider clinics with community health workers.
CHWs are located in the clinic and address social and behavioral determinants.
b. Cancer Services partners with community agencies and providers.
c. Cancer Services partners with Cancer Mission 2020 to suggest policy and
environmental change to prevent cancer, especially lung, breast and colon.
d. Communicable Disease Surveillance has developed a multi-hospital collaborative that
has significantly decreased the incidence of central line infections. The collaborative is
multidisciplinary involving many hospital workers at all levels. The collaborative is
established as a sustainable infrastructure for decreasing infectious disease throughout
the county.
e. Communicable Disease Surveillance Emerging Infections Program partners with the
Monroe County Dept of Health through a non-funded grant to provide infrastructure
support, monitoring and reporting in case of an outbreak.
f. Community partnerships are supported through the Community Advisory Council that
links CBOs, faith community, local government, media and school district with the
URMC.
g. Community Partnership facilitates the relationships between and within many coalitions
and with URMC through years of collaboration and mutual respect.
h. CH Policy collaborates with several community partners to identify policy solutions to
health problems such as HealthiKids, PlayBest, LEAD Coalition, Health Impact
Assessment, etc.
i. CH Policy mobilizes hospital systems to partner with the health department and FLHSA
to develop the Monroe County Community Health Improvement Plan based on data and
community input for NY and IRS reporting.
j. HEART leadership team, which represents over 20 community and governmental
organizations, works together to transform the community. Community agencies are
linking and coordinating services.
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k. HEART has been approached by several individual neighborhoods asking to partner on
grant opportunities for healthy community improvements.
l. HEART initiatives such as school health index and CEPTED mobilize communities
within schools and neighborhoods to address health issues such as safety and poor food
selections.
m. The Diabetes Prevention Program coordinates services between six different clinical
sites to avoid duplication and maximize usage of services to patients diagnosed with
pre-diabetes.
n. Healthy Hero works with partner agencies to implement their program and to meet
families in their communities.
o. PBRN promotes partnerships between practitioners, researchers and community
members.
p. Rochester Walks building walking clubs among community members to encourage peer
support for active lifestyles.
q. TEEN HSP participates in NYSDOH, HWSC and Rochester City School District and
other community agencies strategies groups/committees that focus on teen health issues.
5. Develop policies and plans that support individual and community health efforts.
a. CCH Communications developed “Speaker Guidelines” that are based on CDC
guidance that promote health literacy in any public health education engagement.
b. Communicable Disease Surveillance helped develop hospital policies to reduce hospital
acquired infections.
c. Community Advisory Council developed the “Guiding Principles for Community-Based
Research” to help researchers base their questions on community needs and a process
for community endorsement.
d. Community Partnership developed the “Principles for Partnership” that were adopted by
several coalitions to keep coalition meetings fair and on task.
e. CH Policy was integral in the development and implementation of Lead policy in
Monroe County. CH Policy advocated for complete streets policy and healthy corner
stores policy in City of Rochester through the HealthiKids coalition.
f. HEART smoking-free clean indoor air policy in public outdoor space, college campuses
and multi-unit housing was supported and some initiated.
g. HEART teams in Rochester City Schools are developing policies based on the School
Health Index to improve the physical environment and nutrition.
h. HEART active transportation coordinator is developing policies to improve the
environment through trails, bike paths and slower traffic improvements.
i. HEART worksite wellness index will suggest policy and environmental changes to
businesses for adoption based on an internal assessment.
j. Rochester Walks is making environmental improvements by and marking walking
routes with signage and mile markers.
6. Enforce laws and regulations that protect health and ensure safety.
None.

101
ASSURANCE
7. Link people to needed personal health services and assure the provision of health care
when otherwise unavailable.
a. The BPAP program links high risk hypertensive patients to community resources and
empowers patients to ask questions of the primary providers.
b. Breast Health Awareness program reminds insured women to get mammograms and
assists with finding providers and services.
c. Cancer Services provides screening to uninsured by removing the cost barriers and
facilitating appointments.
d. CCH Communications provides information on our websites and brochures to link
people to services the CCH provides.
e. Sentinel Network links survey respondents to needed health and social services as
appropriate.
f. HEART through health fairs and community interactions serves as a resource for people
who need personal health services and provides links to those services.
g. HEART worksite wellness index will link businesses to services provided at URMC for
employees who work here.
h. Diabetes Prevention Program provides care for patients diagnosed with pre-diabetes to
prevent advancement of the disease.
i. Healthy Living Center providers see patients who are referred from primary care
providers for behavior change therapy that cannot be addressed adequately in the
primary providers’ office.
j. Healthy Living Center providers link their counseling services with the patient’s
primary provider and specialists as needed.
k. Healthy Living Center provides behavior change counseling to employees free of
charge to remove the cost barrier for patients/employees.
l. Healthy Living Program goes into communities to provide exercise and nutrition help to
AA and Latino groups.
m. TEEN HSP Be Healthy Be Successful Health Literacy and Resource Connection
program links teens to health insurance, medical care, dental and vision care.
8. Assure competent public and personal health care workforce.
a. The BPAP program trains community members (14 to date) on health issues, especially
hypertension but also related chronic disease and risky behaviors, and their prevention.
Continuous education is provided to the CHWs currently working on the BPAP
program.
b. The BPAP program developed an 8-session, 24 hour education program for community
organizations including assessment tools that can be used to train community health
workers.
c. Cancer Services informs providers about new screening and prevention guidelines and
updates providers as the evidence base changes.
d. CH Education trains medical students on community health and the importance of
addressing social and behavioral determinants of health and directs the Community
Health Improvement Course for experiential learning.
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e. CH Education facilitates Public Health Grand Rounds and faculty groups to enhance
community health work and professional development of faculty and staff at URMC as
well as students and community members.
f. HEART has trained medical students, residents and undergraduates by providing
community health experience and education through practical learning.
g. Diabetes Prevention Program trains nurses, dieticians and other providers at clinics to
deliver the DPP program and learn diabetes prevention.
h. Healthy Hero uses volunteers who are often students in social work, public health and
nursing and teaches health education and effective community engagement.
i. Healthy Living Center provides clinical internship experience to medical students,
residents, graduate students and undergraduates of all disciplines who want to learn
about motivation theory and health behavior change.
j. Healthy Living Program and Cancer Services provide training and experience for
students studying medicine, nursing and public health.
k. PBRN teaches practitioners about research, evidence-based practice and translation.
l. TEEN HSP through the Hillside Work-Scholar Program teaches students who are at
risk, and who are often from underrepresented communities, about health careers and
offers entry level health jobs to these students.
9. Evaluate effectiveness, accessibility, and quality of personal and population-based
health services.
a. The BPAP program is evaluated for effectiveness both for blood pressure control and
behavior changes within the patient population.
b. Cancer Services evaluates effectiveness of personal health services for their clients.
c. Communicable Disease Surveillance evaluates the effectiveness of vaccine programs
and reports data to the CDC for national effectiveness of the vaccines, especially the
HPV and influenza.
d. HEART evaluates the effectiveness of community transformation through an extensive
intervention evaluation plan.
e. The Diabetes Prevention Program evaluates their programs for effectiveness with a post
intervention study for participants.
f.

The Diabetes Prevention Program evaluates implementation sites for effectiveness and
promotional ability and referrals.
g. Healthy Hero evaluates their interventions for effectiveness immediately post program
and several months after intervention.
h. Healthy Living Center tracks employee wellness information for improvements over
time. Each intervention is evaluated for effectiveness as well.
i. Healthy Living Program studied a comparison with the Diabetes Prevention Program to
see what settings are most effective. Family settings were also evaluated.
j. TEEN HSP has a robust evaluation system that tracks student success as compared to
students not in the Hillside Work-Scholar Program as well as program effectiveness.
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10. Research for new insights and innovative solutions to health problems.
a. The BPAP program provides and innovative solution to supplementing primary care
intervention with high risk hypertensive patients.
b. Communicable Disease Surveillance team is doing research on C-diff in long term care
centers to assess whether the infection is most often acquired at the center or at the
hospital. Also researching antibiotic usage in nursing homes.
c. Community Partnership, although not personally conducting research, facilitates
collaborative relationships which are essential for research to truly be community based.
d. Community Partnership facilitates community members and organizations learning the
research evidence base for health issues and interventions through coalition meetings
and presentations.
e. CH Policy conducts public health systems research to measure the value of investing in
public health infrastructure.
f. HEART is filling the gap in evidence for Deaf Health interventions and is part of the
national return on investment research and evaluation project.
g. Diabetes Prevention Program is conducting extensive research to determine the most
effective setting for successful implementation.
h. Healthy Living Center is researching the use of a ‘virtual clinician’ for diabetes
management and also for lowering cholesterol.
i. PBRN facilitates research that is clinically based and assures translation and community
engagement in research in primary care settings.
j. TEEN HSP researches how preventing high school dropout prevents early mortality and
chronic morbidity; Health literacy and resource connections are being evaluated for
effectiveness of appropriate use of health care resources.

Figure 10. Center for Community Health Contributions to the 10 Essential Public Health
Services
According to the information provided in the interviews, the Center for
Community Health contributes substantially to the 10 Essential Public Health Services.
The service most often mentioned by managers/directors is Essential Service #4:
Mobilize community partnerships and action to identify and solve health problems,
followed by #7: Link people to needed personal health services and assure the provision
of health care, and #3: Inform, educate and empower people about health issues.
Managers/directors did not state that they contributed to Essential Service #6: Enforce
laws and regulations, which is to be expected since the CCH does not have any regulatory
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authority. Managers/directors stated less contributions to Essential Services #2:
Diagnose and investigate health problems, and #1: Monitor health status to identify and
solve community health problems.
Essential Services #5: Developing policies and plans, #8: Assuring a competent
workforce, #9: Evaluating effectiveness, and #10 Research for new insights, are all well
represented, with several managers/directors mentioning programs that service this
function.
Case Study
Blood Pressure Advocacy Program (BPAP): Finger Lakes Regional Economic
Development Council awarded a grant for $300,000 to the Finger Lakes Health System
Agency (FLHSA) to support the development and hiring of Community Health
Advocates (CHA) to address high blood pressure among the high risk population in
Monroe County. FLHSA contracted with the CCH in March 2012 to implement the
Blood Pressure Advocacy Program (BPAP). Contracts were expedited between the
funders and the CCH, as well as Memoranda of Understanding with all four clinic sites
for CHA placement. All agreements were negotiated, edited for compliance, and
initiated within a 4-month time period. Administrative staff was hired within 6 weeks,
and CHAs were hired in July 2012. Clinic care began on August 17th with an
overarching goal of improving blood pressure control in patients of neighborhood health
centers by assisting clinical staff in addressing the social and behavioral determinants of
health.
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Data are being collected by the BPAP supervisor and the evaluator in order to
assess the effectiveness of the BPAP program. The patient data counts were shared with
this researcher in order to evaluate the cost-benefit of the program. A summary of the
number of patients available for the intervention is given in Table 12.

Table 12
Intervention Patients for Blood Pressure Advocacy Program (as of June 7, 2013)
Intervention Patients

Total

Total Patients with HBP in data import

6355

Patients with no visit in last 13 months
Patients with BP ≥ 140/90
Patients with no BP data available
Total patients from import for intervention

294 (5%)
2226 (35%)
334 (5%)
2854 (45%)

Total Patients referred from providers and staff

644

Number of patients completing first visit with CHA

485

Number who exited the program in control

55

Number of “in control” patients who participated

25

Number who intentionally withdrew from program

12

Number currently in BPAP program

410

The BPAP program has been operational since August 2012 and a full assessment
of progress was conducted in June 2013. In the 10 months that the BPAP program had
been seeing patients, all patients at the four intervention clinics that are diagnosed with
high blood pressure (HBP) and whose blood pressure (BP) was recorded as being not in
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control (systolic ≥ 140 mmHg and/or diastolic ≥ 90 mmHg) were contacted for inclusion
in the program. Of the 1,078 patients contacted, 485 patients (45%) met with a
Community Health Advocate (CHA) and completed an intake assessment. Once the
assessment is completed, CHAs work with patients to make behavior changes through
health coaching using CDC best practices centered on smoking cessation, nutrition,
medication adherence, and exercise. As of June 2013, 410 patients (85% of those who
completed the assessment) remained in the BPAP program, while 55 (11%) had exited
the program with their blood pressure in control. When examining the patients who have
visited the CHAs more than one time, there is an average decrease in blood pressure both
in the systolic and diastolic measures. There are 232 patients who had out of control
blood pressure initially, and who have visited the CHA more than once. To estimate the
clinical impact of the BPAP intervention, the changes in blood pressure were measured
between the original blood pressure readings and the most recent blood pressure readings
for those patients who are diagnosed with HBP and whose BP was not “in control” at the
start of the intervention. A paired t test was conducted in SPSS 19 to measure the change
for statistical significance. Table 13 shows that the patients who have visited the CHAs
more than once have seen a statistically significant decrease in their blood pressures
between their original BP reading and the latest BP reading.
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Table 13
Results After 10-Month Blood Pressure Advocacy Program Intervention
Initial

Latest

Mean Change

Significance

Systolic

150 ± 15

132 ± 15

18 ± 20

Paired t(231) = 13.72, p = .000

Diastolic

85 ± 9

78 ± 11

8 ± 12

Paired t(231) = 10.21, p = .000

In order to calculate a financial benefit associated with this change in BP, I
followed the process outlined by Song, Hill, Bennet, Vavasis, and Oriol (2013) for the
cost savings study of a similar intervention. First, the reduction in blood pressure was
converted into reductions in relative risk for myocardial infarction, stroke, and general
cardiovascular disease using the Framingham risk calculators. Next, the change in
relative risk was converted to cases of myocardial infarction, stroke, and cardiovascular
disease avoided through the BPAP program. Last, attributable costs were assigned to
convert risk reduction into savings.
Framingham Risk Calculators were used to calculate patient risk for myocardial
infarction (MI) (http://my.clevelandclinic.org/heart/disorders/cad/heart_center_risk
_tool.aspx), for stroke, and for general cardiovascular disease risk
(http://www.framinghamheartstudy.org/risk/index.html). The average age of the BPAP
patients in the CCH intervention was 57.6 years and the population was split male and
female, leaning slightly towards female 57%. For the risk calculations, the most
conservative answers were chosen, including indicators for no family heart history, no
smoking, and yes to taking medications or being treated since the patients were all being
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seen in one of the clinics. No indications for a history of any comorbidities were chosen
and all parameters were held constant for comparisons, only changing the blood pressure
as indicated by our actual results. These indications for risk factors will yield a
conservative estimate in the change of risk, which realistically is not reflective of our
patient population who most often have elevated cholesterol, smoke, and present with
comorbidities. The midpoint of the obese category was used as a conservative estimate
of our patient population. The predicted reduction in risk for myocardial infarction
within 10 years by decreasing systolic blood pressure from 150 mmHg to 132 mmHg
yields a 2% decrease in risk for both males (12%–10%) and females (4%–3%). The
reduction in risk for stroke within 10 years was 3% for males and 2% for females. The
reduction in risk for “general cardiovascular risk,” including coronary death, MI,
coronary insufficiency, angina, stroke, peripheral artery disease or heart failure,
decreased 5.4% for males (28.3%–22.9%) and decreased 4.6% for females (15.9%–
11.3%).
The sample population that experienced the blood pressure change through the
BPAP intervention consisted of 232 patients at the end of 10 months. Using the average
decrease in risk between males and females and applying that risk to our patient
population, we determine that the decreases in risk for MI equates to 4.64 MI cases, 5.8
cases of stroke, and 11.6 cases of general cardiovascular injury averted.
In order to calculate cost savings, the excess medical care cost per case for the
hospital was examined using the O’Sullivan et al. (2011) research, which studied
administrative claims data to predict medical care costs of 15 different cardiovascular
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events (O’Sullivan et al., 2011). The 36-month post-event attributable costs for nonfatal
MI (adjusted to 2013 rates) were calculated to be $87,524 per patient. The 36-month
post-event attributable cost for ischemic stroke was $23,881 and for hemorrhagic stroke
was $85,490 per patient. The most common category of general cardiovascular injury is
angina. Non-surgical angina is estimated to add $42,986 cost per patient for the 36month post-angina event time frame. For the risk reduction from the decrease in blood
pressure achieved by the 232 patients in the BPAP program, total predicted cost savings
are $406,111 for MI, $138,510 for ischemic stroke, and $498,638 for angina. These
savings assume that the patients maintain their lower blood pressure during the time
frame of the risk assessment, which admittedly is a large assumption. The BPAP
investment as a whole was $300,000 for the first year, so the cost has been recovered in
the risk reduction for just these few acute cardiovascular events. If we examine just the
general risk reduction for cardiovascular injury and assume that angina represents a
typical cost, the $498,368 can be considered benefits compared to the $300,000 total cost
for the program. The cost benefit would result in a $198,368 “profit” that contributes to
one program’s offset of the cost of the UR investment in CCH ($887,450 for FY12). As
a case study, this is one example of the many services provided at the CCH, all of which
have potential to impact health outcomes that result in long-term cost savings.
Besides the BPAP program, several other service areas and programs have
measured outcomes that contribute to the value added by the CCH. These outcomes were
mentioned in the interviews and are recorded here as additional information to the study.
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Community Engagement: The Community Advisory Council (CAC) was
established by CCH to advise URMC on community needs. Thirty-one community and
academic members comprise the CAC, and 18 community-based organizations, including
health and social service agencies, the faith community, local government, the city school
district, and media are represented. The CCH serves an important role on the African
American Health Coalition and the Latino Health Coalition and at last count had
membership in 26 unique community coalitions. The value of community engagement is
difficult to quantify. Several researchers at the CCH have written a paper titled
“Evaluating Community Engagement in an Academic Medical Center,” which is being
reviewed.
Cancer Services: For 2012-13 grant year, the Cancer Services Program in
Monroe County (CSP-MC) enrolled more than 1,800 men and women into the program,
and screened almost 1,500. More than 5,300 individuals have been screened since April
1, 2009. If screening indicates a suspected cancer, CSP can pay for additional testing. If
a client is diagnosed with breast, cervical, colorectal, or prostate cancer and has no
insurance to cover treatment, CSP will assist them in applying for coverage through
Medicaid or funding treatment is some other way. During the 2012-12 service year, 567
people needed follow-up services of some kind. A total of 36 cancerous or precancerous
conditions were found in this year alone.
Communicable Disease Surveillance and Prevention: The C-diff prevention
collaborative program calculated estimated cost savings on a quarterly basis related to
hospital-onset C. difficile infections for the four major hospitals in the Rochester area.
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This was done by assigning an excess cost of $14,000–$34,000 to each C. diff case
(based on hospital billing information) and looking at the change in cases over time. The
excess cost is based on an unpublished administrative study at two of the four hospitals
where the cost of patients with (cases) and without C. diff (controls) were compared after
matching the case and control patients by DRG group. Overall cost savings are given in
Table 14. The communicable disease surveillance and prevention central line associated
bloodstream infections collaborative saved the hospitals an estimated $560,000–
$1,360,000 for one year just in prevention efforts for hospital acquired c-diff.

Table 14
Changes in Attributable Cost of Health Care Facility-Associated C. Difficile 2011-12
Facility

Number of Cases

Change in # of Cases
2011-12

Estimated change
attributable cost
2011-12

2011

2012

Hospital A

194

143

–51

Decrease
$714,000 – $1,734,000

Hospital B

212

240

+28

Increase
$392,000 – $952,000

Hospital C

85

75

–10

Decrease
$140,000 – $340,000

Hospital D

90

83

–7

Decrease
$98,000 – $238,000

581

541

–40

Decrease
$560,000 – $1,360,000

Total

A similar intervention was conducted looking at all hospital central line infections
outside of the intensive care units. Central Line Associated Bloodstream Infections
(CLABSI) pose a significant risk to patients in hospitals. This was a 5-year funded
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research project from the New York State Department of Health. In the first year of the
project, 175 CLABSI were observed, and in 2012, the fifth year of the intervention, only
38 CLABSIs were observed. A cost study was conducted to assess and estimate the
attributable excess cost of CLABSI and that research yielded $45,560 per infection,
which is a bit higher than the excess cost in the literature of $7,288–$29,156 per infection
(Scott, 2009). The potential number of CLABSI, if no intervention had taken place,
could have reached 525 over 3 years (the post-intervention period). Hospitals in the
collaborative experienced a total of 224 infections over that 3-year period. Using these
numbers, 301 fewer CLABSI than predicted actually occurred, yielding a conservative
estimated overall cost savings between $2,193,688–$8,775,956 using Scott’s estimate or
as much as $13,713,560 when applying our cost estimate.
Chapter Summary
A multiple-methods retrospective analysis of the value change associated with the
development and growth of the Center for Community Health (CCH) was conducted.
This longitudinal case study of the CCH involved costs and benefits as well as growth in
community health capacity over a 6-year period starting with the initial contribution of
University of Rochester to the Center for Community Health in May 2006 and continuing
through June 2012.
Research was conducted to ascertain if investing in public health system capacity
provides value and whether that value change can be quantified in economic terms.
More specifically, the research examined whether the University of Rochester’s
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investment in the development and growth of the Center for Community Health, a
partnership extension of the local public health system, provided a value benefit either
financially or in the health of the community.
Financial value was calculated after collecting and analyzing several sources of
financial data from the CCH and from the UR accounting systems. The total CCH
budget has grown each year since its inception. UR infrastructure support has been
constant at around $850,000 annually; however, extramural awards have steadily
increased from $12,943 in the first year to $4,577,375 in FY12, which represents a 516%
return on the UR investment. CCH was able to increase the indirect costs recovered that
support UR administrative and utility expenses each year, somewhat offsetting the UR
investment.
The extremely large return on investment is not paid back to UR in financial
returns, since the function of the CCH is not to turn a profit, but rather to improve the
community’s health. The return on investment is delivered in increased capacity to
improve community health. Increasing numbers of staff and faculty have been hired
through the CCH since its inception to increase the county public health workforce.
According to the information provided in the interviews, the Center for Community
Health contributes substantially to the 10 Essential Public Health Services. The service
most often mentioned by managers/directors is Essential Service #4: Mobilize
community partnerships and action to identify and solve health problems, followed by
#7: Link people to needed personal health services and assure the provision of health
care, and #3: Inform, educate, and empower people about health issues. Essential
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Services #5: Developing policies and plans, #8: Assuring a competent workforce, #9:
Evaluating effectiveness, and #10: Research for new insights, are all well represented,
with several managers/directors mentioning programs that service this function.
To more concretely demonstrate improved community health, a case study of the
Blood Pressure Advocacy Program was examined. The CCH had the infrastructure and
capacity to win the BPAP funding award, and during the first year of its start-up and
implementation, Community Health Advocates were able to lower the blood pressure
significantly on 232 high-risk patients diagnosed with hypertension. The program
achieved estimated savings of $544,621 from the decreased risk of MI and stroke in the
patient population.

CHAPTER V
DISCUSSION
Chapter Overview
Demonstrating value for investment in public health system capacity building is
critical to inform funding and policy decisions. This project describes a process for
quantifying value using economic/financial techniques and provides an example of
assessing return on investment. The public health system, including governmental public
health as well as system partners, plays an important role in health care in the United
States. The value of prevention and community health has grown with the discussion of
health care reform and the passage of the Affordable Care Act. Health care costs are
growing and early primary prevention initiatives, especially those delivered in the
community setting, have potential to provide cost savings. Practitioners and researchers
must be prepared to show value for investments made in public health infrastructure.
Funding is tight and financial decisions must be justified with objective data
discussed within a logical and relevant context. Economic evaluation and the ability to
translate economic analysis into practice and advocacy can help policy makers and
practitioners make efficient use of valuable resources. Frameworks are needed to assist
public health practitioners translate their message, understand economic analysis, and
showcase their added value to policy makers.
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The public health system must adjust its capacities to meet changing demands,
including altered strategies to prevent chronic disease as well as fiscal accountability.
Often this is best served when public health systems expand their partnerships to
effectively address some essential services. Partnership and sustainability demand
accountability, both in health outcomes and cost benefit. To date, little research has been
done on the economics of public health systems and services, especially at the local level.
The Monroe County Department of Public Health (MCDPH) has partnered with
the University of Rochester (UR) to develop the Center for Community Health (CCH), an
academic medical center within the University of Rochester (UR), and the subject of this
research. The UR invests substantially and annually to the development and growth of
the CCH to fulfill a pillar of its mission of improving community health. This
dissertation work studies financial data and explores the work of the CCH to answer the
research question: Does the University of Rochester’s investment in the development
and maintenance of the Center for Community Health, a partnership extension of the
local public health system, provide a value benefit either financially or in the health of
the community? This is a question that all funders ask of their partner agencies, and one
that public health practitioners should be well prepared to answer. This research provides
a replicable model for public health organizations to duplicate when assessing the value
of their agencies.
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Summary of Design and Results
A multiple-methods retrospective analysis of the value added with the
development and maintenance of the Center for Community Health (CCH), a unique
naturally occurring experiment, was conducted. This is a non-experimental, longitudinal
study of costs and benefits as well as growth in community health capacity over a 6-year
period starting with the initial contribution of University of Rochester to the Center for
Community Health in May 2006 and continuing through June 2012. Financial records of
the CCH were analyzed to produce a time series picture of the use of the UR investment.
Interviews were conducted of managers and directors within the CCH to capture gains in
public health capacity. A case study was also conducted to evaluate health outcomes and
the associated cost savings of one particular program within the CCH.
The results of the analysis show that the total CCH budget has grown each year
since its inception. UR infrastructure investment has been constant at around $850,000
annually; however, extramural awards have steadily increased from $12,943 in the first
year to $4,577,375 in FY12, which represents a 516% return on the UR investment. In
addition, CCH was able to increase the indirect funds that support UR administrative and
utility costs each year, somewhat offsetting the annual UR investment. Indirect cost
recovery totaled 55% of the UR investment for FY12.
The large return on investment is not paid back to UR in financial returns, since
the function of the CCH is not to turn a profit, but rather to improve the community’s
health. The return on investment is delivered in increased capacity to improve
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community health. This increased capacity is evident in many ways, including the
increase in staff and faculty hired through the CCH over the years. The CCH workforce
increased from 13 employees (12.6 FTEs) in FY06 to 63 employees (46.7 FTEs) in
FY12. The increased faculty and staff have been able to build public health capacity by
fulfilling the 10 Essential Public Health Services. According to the information provided
in the interviews, the Center for Community Health contributes substantially to the 10
Essential Public Health Services. The service most often mentioned by
managers/directors as a function of their work is Essential Service #4: Mobilize
community partnerships and action to identify and solve health problems, followed by
#7: Link people to needed personal health services and assure the provision of health
care, and #3: Inform, educate and empower people about health issues. Also, #5:
Developing policies and plans, #8: Assuring a competent workforce, #9: Evaluating
effectiveness, and #10: Research for new insights, are all well represented with several
managers/directors mentioning programs that service this function.
The research demonstrates that CCH has been able to turn the UR investment into
substantially increased funds that are being used to improve the public health
functionality. To more concretely demonstrate improved community health, a case study
of the Blood Pressure Advocacy Program (BPAP) was examined. During the first year of
the BPAP’s start-up and implementation, Community Health Advocates (CHAs) were
able to lower the blood pressure significantly on 232 high-risk patients diagnosed with
hypertension. The program achieved estimated savings of $544,621 from the decreased
risk of myocardial infarctions and stroke in the patient population enrolled in BPAP.
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Other CCH programs and services have demonstrated cost savings through their
interventions. For example, the CLABSI program saved the area hospitals between
$2,193,688 and $8,775,956 over their 3-year intervention, and the communicable disease
surveillance and prevention central line associated bloodstream infections collaborative
saved the hospitals an estimated $560,000 – $1,360,000 for one year, just in prevention
efforts for hospital acquired c-difficile. Many other service areas and programs are very
successful in improving community health; however, their outcomes have not been
converted to monetary measures. A true picture of the entire value added by the UR
initial and growth investments in the CCH can only be fully realized by economically
analyzing all health outcomes.
Discussion of Results
It is clear from this research that the Center for Community Health adds value to
the University of Rochester and that there is a valuable return on the investment that UR
makes in the CCH annually. It is also clear that the value added can be quantified, as
demonstrated in the results section.
Value can certainly be assessed through financial gains; however, the CCH goal is
not to produce a financial profit. Most grant funding and private awards require that
funds be used to complete the work plan of the award contract so that all funds are used
to do the work, in this case, of community health. However, this is not to say that cost
savings and realized returns are not important, just that the savings are often absorbed in
increased intervention or service delivery so that funding is “break-even.” Therefore
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value cannot be measured in improved profits, but rather in the additional work that those
profits can fund.
The UR has steadily supported CCH with an annual investment that is used for
infrastructure support (as shown in the operating budget, Table 6.) However, through
that support, CCH has been able to apply for and win several extramural awards,
resulting in a 5-fold budget increase since the CCH’s inception. Not only has funding
increased substantially, but funding sources have changed and larger, federal, longer-term
grant funding has increased. Extramural funding supports the work that the CCH is able
to accomplish and the more funding received, the more community health work can be
achieved. Federal funding is also important for dissemination of findings and networking
with experts nationwide. UR infrastructure support has allowed the CCH to build strong
internal systems for community partnership as well as health monitoring and tracking that
makes the Center a desirable recipient for extramural funding.
Increasing extramural funding has resulting in increased indirect cost recovery to
the University, although not all extramural funding allows for indirect cost allocation.
The CCH is cognizant of the allowable indirect costs payable when applying for
extramural funding; however, the potential to improve community health always takes
priority over indirect funding allotment.
In addition to the grants given directly to the CCH, there is value that is difficult
to quantify in the additional funding to the UR, and to the community partners, that is
made possible by the existence of the Center. For example, the Clinical and Translational
Science Award was given to the UR and the CCH has the responsibility of the
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Community Engagement function. The CCH was well established and capable to serve
this function when UR applied for the very substantial CTSI award. In addition, Finger
Lakes Health System Agency recently was awarded the largest Centers for Medicare and
Medicaid Innovations (CMMI) award in the nation. The Director of the CCH was
instrumental in assisting with the system design that was articulated in the grant
application, and advocated for community health partnership in the clinical design model.
The increased overall budget of the CCH has been used to increase community
health work through increases in staff and increases in the service delivery. The URMC
has as part of its mission and strategic plan to “improve the health of the community.”
The mission of public health is to promote physical and mental health while preventing
disease, injury, and disability. The 10 Essential Public Health Services were introduced
to measure how well the health department is designed to reach the mission; presumably,
the better an organization performs the essential services, the more likely they are to
improve health and prevent disease. The same principles were applies to the CCH as a
public health partner. The 10 Essential Public Health Services are carried out across the
14 key programs and services of the CCH. The essential services cover three core
functions defined in the 1988 IOM report: (1) Assessment or monitoring the health status
of a community; (2) Policy development, implementation, and advocacy; and
(3) Assuring the community has access to competent and effective community health.
Through interviews with each of the program managers or directors at the CCH, the
research demonstrated a broad body of work that covers all three core functions. The
CCH did not have any activity that contributes to enforcing laws and regulations that
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protect health and ensure safety; however, that is to be expected since as a partner
organization in an academic institution, we have no legal authority to do so. The CCH
did, however, contribute substantially in areas that are traditionally not done by local
public health, including developing policies and plans, evaluating effectiveness of
personal and population-based health services, and conducting research for new insights
and innovative solutions to health problems. As public health systems grow and new
partners are added, it will be important to match partners that have great capacity to
complete essential services beyond the scope of a particular governmental health
department. Research is a key example: research might be more easily and efficiently
conducted in an academic medical center than in a practice-based public health
department.
Another important essential function that is conducted by many service areas
within the CCH is mobilizing community partnerships and action to identify and solve
health problems. The CCH was established in part to be the link between the UR and the
community; therefore, it is of value that we have such substantial contributions to this
essential service. In addition to the many activities listed during the interviews, the
Director of Community Engagement is tracking community encounters and partners.
Thirty-one community and academic members comprise the Community Advisory
Council which is led by the CCH, and 18 community-based organizations, including
health and social service agencies, the faith community, local government, the city school
district, and media are represented. In addition, the CCH had membership in 26 unique
community coalitions. Beyond participating in community groups, the CCH has been
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able to support our community partners financially and has contributed $568,635 in
contracts and agreements with community-based organizations.
Although this research has shown substantial value returned on the investment of
the UR through financial growth as well as community health capacity, it is difficult to
demonstrate improved community health resulting from the UR investment. There is not
a clear singular measure for improved community health, and that measure changes
depending on the service area. Examining all the service areas within the CCH for
community health improvement is beyond the scope of this dissertation; however, a case
study example was presented. The Blood Pressure Advocacy Program (BPAP) is a
recent initiative that was funded through the state economic growth initiative, via
subcontract with the Finger Lakes Health Services Agency. The CCH was selected for
this funding contract because of its ability to get the program started quickly, to initiate
and complete contracts in a timely manner, to develop and implement a training program
based on established curriculum and national guidelines, and to translate evidence-based
practices into a clinical setting within a matter of months. Were it not for the
establishment and growth of the CCH, UR would not have been a candidate to receive
this funding award of $300,000 to oversee the program. Within the first year of the
program, the CCH BPAP program has actively worked with over 400 patients referred by
providers or through phone solicitation. Among all the clinic patients with high blood
pressure that is not controlled, four community health workers are actively counseling
232 patients. These patients have seen substantial health outcomes, including an overall
decrease in blood pressure from 150/85 to 132/78, a statistically significant difference

124
(paired t(231) = 13.72, p = –.000). Converting that change in blood pressure to long-term
cost savings, this change is estimated to result in 4.64 less myocardial infarctions (MIs)
and 5.8 less cases of stroke. Overall, we can expect 11.6 cases of general cardiovascular
injury averted, resulting in substantial decreases in cost in medical care—$544,621 in
costs savings for the 3-year period following MI and stroke cases averted. This savings
benefit is offset by the $300,000 cost needed to run the program for one year, with
remaining balance of $244,621 in savings. Theoretically, that savings can be matched
against the UR contribution for FY12 of $887,450.
Each service area within the CCH has both potential and realized health outcomes
that can be quantified and converted to net savings or net cost. The BPAP program
alone, along with the indirect cost recovery ($487,535), comes close to covering the UR
contributions for FY12.
Conclusions and Implications
This research shows that the UR annual investment yields substantial value in the
financial return of over 500% for FY12, which was used to increase the public health
capacity in our community and to improve health outcomes. The true and complete
measure of community health improvement is difficult to quantify; however, that does
not diminish the value that has been quantified.
A Framework for Assessing Value in Public Health Systems was presented in this
dissertation and may be used by practitioners to summarize value and to disseminate the
findings to decision makers, including funders. Step 8 in the framework is to “write the
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story for the decision makers using the outcome of value.” The results should be
presented in a succinct and understandable manner to persons who might not be familiar
with public health or prevention concepts. The sample summary for the evaluation of the
Center for Community Health, as presented to the University of Rochester, would read as
follows.
A retrospective analysis of the Center for Community Health was conducted to
study the value added through the annual contributions of the University of
Rochester from the CCH inception in May 2006 through the last complete fiscal
year that ended June 30, 2012. The University is interested in supporting a
fiscally responsible Center that was established to contribute to the mission of
improving the community’s health. The University’s contribution leads to
improved health outcomes in the following way:
1. Investments from the University have remained steady through the six years
since the Center was established. The CCH has been able to grow that money
by applying for extramural funding which has increased every year. The UR
investment as a percent of the annual budget is decreasing each year and the
indirect funds collected for UR have increased.
Center for Community Health Funding
$6,000,000
$5,000,000
$4,000,000
UR Support

$3,000,000

Total Awards

$2,000,000

TOTAL FUNDING

$1,000,000
FY12

FY11

FY10

FY09

FY08

FY07

FY06

$0

2. The CCH has been able to use the increasing extramural funding to build
community health capacity by expanding our health workforce from 13 to 63
individuals, increasing the services and programs we are able to provide,
growing and financially supporting our partnership organizations ($568,635
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given to community agencies through contracts in FY12) and evaluating and
researching our successes. The CCH has contributed significantly to the 10
Essential Public Health Services, including:
Monitoring the health status of Monroe County through our
communicable disease surveillance, the Monroe County Adult Health
Survey and the evaluation of the employee biometric screenings.
Informing, educating, and empowering people about health issues through
conducting community health forums, teaching through one-on-one
interventions in Healthy Hero, Blood Pressure Advocacy Program, Teen
Health and Success Partnership, and the Diabetes Prevention Program.
Mobilizing community partnerships through many initiatives including the
Practice Based Research Network, the Community Advisory Council, the
African American Health Coalition, and membership in 26 unique
community coalitions.
Developing policies that support community health efforts including
supporting clean indoor air initiatives, environmental improvements
including the Rochester Corner Store Policy, Complete Streets
Legislation, and the H.E.A.R.T. initiative funded through the CDC.
Research for innovative solutions exploring the Diabetes Prevention
Program, and implementation strategies, as well as the Healthy Living
Center studying virtual clinicians and self-motivational theory for
behavior change.
3. Increased community health capacity has led to improved community health
and health impacts. As an example, the Blood Pressure Advocacy Program
was able to significantly decrease the blood pressure of 232 high risk
hypertensive individuals who are engaged in routine counseling sessions with
Community Health Advocates at community clinics. This decrease in blood
pressure equates to over $500,000 in savings from preventing 4.6 heart attacks
and 5.8 strokes in this patient population alone.
Sustained operational funding has yielded a return on investment for the UR not
only in financial gains but more significantly in the ability to do more work to
improve the health of the community.
Public health practitioners and systems researchers must begin to study the
financial and economic implications of their work. A strong business case for an
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intervention or infrastructure support is a powerful advocacy tool for resource allocation
decision makers.
Study Limitations
There are several limitations to this research. This is not a randomized-control
trial but rather a retrospective observational study of one system’s experiences that can be
applied to other systems as appropriate. Being retrospective and observations, reliability
of the historical data is only as strong as the key informants who are interviewed.
Likewise, when assessing each CCH program for its contributions to the 10 Essential
Public Health Services, the data are dependent on the manager’s or supervisor’s
knowledge of the services provided and honesty in reporting only those services
provided. Ideally, a second data source could be constructed by interviewing community
partners and/or community members. Managers’ categorization of services among the 10
Essential Services is subject to social desirability bias, which may lead informants to
overstate compliance. This will be minimized by having the researcher also categorize
the services for comparison and discussion with the managers.
This is an observational study and, therefore, no control group is included for
comparison. Unfortunately, we cannot ascertain what the CCH financial progression
would have been without the UR investment, nor can we compare the growth of the CCH
after its inception in May 2006, to the growth prior to the inception since these financial
data are not as accurate.
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There is a substantial limitation in the inability to accurately measure community
health impact caused by the URMC investment in the development and growth of the
CCH. Causation is extremely difficult to demonstrate in the best of circumstances, and
given the added complications of time lag with prevention efforts and inconsistency in
appropriate health outcomes, is not possible in this study.
Since this is an economic analysis, there are added limitations with the financial
data. Information has been collected and categorized over the past 6-year time frame and
the CCH has experienced unusual turn-over in financial department staff. Consequently,
some financial information collection or categorization procedures may have changed
over time, leading to inconsistencies. When possible, this researcher discussed any
discrepancies with the CCH director and/or the CCH Chief Operating Officer, both of
whom have been with the CCH since its inception. In addition, there are many financial
returns that are beyond the scope of this study, such as those related to improved social
circumstance, or improved productivity of clients impacted by the CCH. In addition, inkind contributions are often given to the CCH in the form of volunteers or student work.
Since this information has not been accurately tracked across the 6-year time span, inkind contributions were not quantified.
Also unique to financial data collection is the difference in fiscal years among
granters and the CCH. Most extramural awards have budget years that are not consistent
with the CCH fiscal year; assignment of funds to a given fiscal year is somewhat
subjective as the funds were split by date and not specifically tracked. Grants awarded in
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October of 2010, for example, would be listed in the UR financial system as being
administered in FY10, however, would be counted in the CCH FY 2011.
Recommendations for Future Research
Standardized outcome measures are needed in the study of public health. A
consistent recognized outcome of improved community health would enable accurate
comparisons between agencies. Understandably, this is a daunting task as community
health encompasses so many diverse parameters. However, measuring the association
between improved community health capacity through the 10 Essential Public Health
Services and improved community health outcomes should be researched.
Although this research contributed to the literature addressing the Public Health
Services and Systems Research Agenda, specifically
What measures provide the most valid and reliable indicators of the financial
performance of public health agencies?
How do investments in public health strategies influence the need for
downstream spending on medical care and/or social services?
much more work is needed in financial and economic analysis of systems research. It is
difficult to apply economic measures of success to public health endeavors primarily
because public health sees value not in financial gains but in the health of the community.
The “financial success” is in improved community health, which to date has been very
difficult to measure. However, the fact that there are many uncertainties should not stop
public health practitioners and researchers from quantify the value in the work they do.
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Interview Protocol and Script
Recruitment Email Letter
Initial Email:
To program managers and service directors at CCH: As most of you know, I am working on my
dissertation to finish my PhD in Interdisciplinary Health Sciences at Western Michigan
University. My study is titled “Quantifying Value in Public Health: Using Economic Methods to
Analyze System Change”. I am studying whether or not the University of Rochester’s investment
in the Center for Community Health has added value either in financial gains or in contributing to
the 10 Essential Services of Public Health Systems. I will be reviewing each of your areas and
programs to determine which, if any, of the 10 Essential Services your work contributes to. In
order to confirm that my interpretation is consistent with your thinking, I would very much like to
interview each of you as key informants. The interview should take one session of between 1530 minutes of your time. You can decide to stop the interview at any time you wish. Although I
know each of you, no personal identifying information will be collected or published in my
research.
If you are willing to discuss your service area with me, please reply to this email at your earliest
convenience to set up our interview time. If you are not interested, please reply to this email to
let me know that. Thank you so much for your consideration.

Follow up Email:
Sorry to bother you, but I am following up on the email I sent earlier requesting your participation
in a brief key informant interview about your service area, and how your work fits with the 10
Essential Services of Public Health Systems (see previous email, below). Please respond to let
me know if you are interested in participating or not. If interested, I would like to set up a brief
interview time as soon as possible. Thank you.
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Consent Form
Western Michigan University
Interdisciplinary Health Sciences
College of Health and Human Services
You are invited to participate in a research project entitled “Quantifying Value in Public Health:
Using Economic Methods to Analyze System Change”, designed to analyze the whether the
University of Rochester’s investment in the development and maintenance of the Center for
Community Health, a partnership extension of the local public health system, provides a value
benefit either financially or in the health of the community. The key informant interview is
designed to assess how services and programs in the Center for Community Health fit with the
10 Essential Services of a Public Health System. This study is being conducted by faculty
member Dr. Kieran Fogarty and student investigator Theresa Green and from the
Interdisciplinary Health Sciences Program at Western Michigan University.
This interview is comprised of 3 open ended questions and will take approximately 15-30
minutes to complete. Your replies will be recorded by written notes taken during the interview
process which can be reviewed by you at any time. You will be identified as the
“Manager/Director of key service area or program”. You may choose to not answer any
question. Signing below and answering the questions indicates your consent for use of the
answers you supply. Participation in this interview is voluntary and if you choose to not
participate, simply state that you wish to stop the interview at any time. Your responsibilities at
the Center will not be affected in any way by whether or not you complete the interview. If you
have any questions regarding this study, you may contact Dr. Kieran Fogarty (269-387-8447), the
Human Subjects Institutional Review Board (269-387-8293) or the vice president for research
(269-387-8298). A final report regarding the project will be available from Theresa Green upon
request.
This consent form has been approved for use for one year by the Human Subjects Institutional
Review Board as indicated by the stamped date and signature of the board chair in the upper
right corner. You should not participate in this project if the stamped date is more than one year
old.

Name

Date

142
Interview Script
Thank you for agreeing to participate in this interview.
1. What services or programs do you provide that might be considered part of public health
system delivery

Assessment

2. After reviewing the 10 Essential Services listed below, where do you think your
programs or services fit? Name as many as you think are appropriate, and it may be that
your services do not match any of the public health 10 Essential Services.
1.Monitor health status to identify
and solve community health
problems
2. Diagnose and investigate health
problems and health hazards in the
community.

Policy

3.Inform, education and empower
people about health issues
4. Mobilize community partnerships
and action to identify and solve
health problems.
5. Develop policies and plans that
support individual and community
health efforts.
6. Enforce laws and regulations that
protect health and ensure safety.

Assurance

7. Link people to needed personal
health services and assure the
provision of health care when
otherwise unavailable
8. Assure competent public and
personal health care workforce
9. Evaluate effectiveness,
accessibility, and quality of
personal and population-based
health services.
10. Research for new insights and
innovative solutions to health
problems.

3. In your opinion, does your service or program area add financial value to the University
of Rochester? Please explain.
Thank you.

Appendix B
Human Subjects Institutional Review Board
Letter of Approval
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